STOCK TITAN

Graham Holdings Q3 earnings fall to $75.1M

Nine-month common-stockholder income was $385.3 million, while third-quarter earnings and operating cash flow were lower than a year earlier.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Graham Holdings Company reported third-quarter 2026 revenue of $1.326 billion, compared with $1.279 billion a year earlier, and operating income of $85.5 million versus $67.1 million. Net income attributable to common stockholders was $75.1 million, down from $122.9 million; the quarter included a $15.0 million loss on marketable equity securities, compared with an $84.8 million gain a year earlier. Nine-month common-stockholder income was $385.3 million, versus $183.6 million, including a $68.1 million U.S. income-tax benefit related to the restructuring and sale of Kaplan Languages Group (KLG).

Operating cash flow for the first nine months was $280.8 million, compared with $318.9 million a year earlier. In June, the company used $113.9 million from pension-plan assets to purchase an annuity contract settling $124.3 million of pension obligations; the insurer now pays and administers benefits for approximately 1,080 retirees and beneficiaries, with no change in payment amount, timing or form. Kaplan's Dublin Business School sale, classified as held for sale at September 30, closed October 27, 2026; KLG's sale closed May 1, 2026 and was associated with a $5.2 million non-operating loss.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 2 points

How the balance works

Positive

  • Moderate pointThird-quarter operating income rose to $85.5 million from $67.1 million.
  • Moderate pointNine-month common-stockholder income rose to $385.3 million from $183.6 million.

Negative

  • Moderate pointThird-quarter common-stockholder income fell to $75.1 million from $122.9 million.
  • Moderate pointNine-month operating cash flow declined to $280.8 million from $318.9 million.

Filing Explained

The $15.3 million Pillar Two accrual could be reversed in full without payment if relevant jurisdictions enact the Side-by-Side Safe Harbor.

For the nine months ended September 30, 2026, Graham reports $198,598 thousand of cash used for common-share repurchases. In October 2026, it acquired the remaining 49% of Skin Clique for $18.4 million, bringing its ownership to 100%.

The filing records $15.3 million of Pillar Two top-up tax expense for the nine months. It says the UK and some other participating jurisdictions had not enacted the Side-by-Side Safe Harbor, and enactment could allow a full reversal of this accrual without payment.

Revenue $1.326 billion Three months ended September 30, 2026; $1.279 billion in 2025
Income from operations $85.5 million Three months ended September 30, 2026; $67.1 million in 2025
Net income attributable to common stockholders $75.1 million Three months ended September 30, 2026; $122.9 million in 2025
Net income attributable to common stockholders $385.3 million Nine months ended September 30, 2026; $183.6 million in 2025
Net cash provided by operating activities $280.8 million Nine months ended September 30, 2026; $318.9 million in 2025
Pension annuity contract purchase $113.9 million June 2026; settled $124.3 million of pension obligations
EBITDAP financial
"Earnings Before Interest, Income Taxes, Depreciation, Amortization and Pension Service Cost (EBITDAP)"
mandatorily redeemable noncontrolling interest financial
"mandatorily redeemable noncontrolling interest"
A mandatorily redeemable noncontrolling interest is a minority ownership stake that the issuing company is legally required to buy back or repay at a set future date or upon a specific trigger. Think of it as a hybrid between an ownership share and a timed loan — it gives outsiders a stake today but creates a known cash obligation later. Investors watch it because it can change reported leverage, reduce future cash available for operations or dividends, and affect how risky the company appears.
Pillar Two top-up income tax regulatory
"Pillar Two top-up income tax accrual and expense"
contract asset financial
"recognized a contract asset of $29.0 million"
A contract asset is a company's right to receive payment for goods or services it has delivered but has not yet billed the customer, recorded when the work is done before formal invoicing. It matters to investors because it shows revenue that’s been earned but not yet converted to cash or an invoice, revealing how quickly the business turns work into billable claims and the quality and timing of its reported revenue; like a completed job waiting for the official bill.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were GHC's third-quarter 2026 revenue and earnings?

GHC reported revenue of $1.326 billion and net income attributable to common stockholders of $75.1 million for the three months ended September 30, 2026. The comparable 2025 figures were $1.279 billion and $122.9 million.

How much did GHC earn in the first nine months of 2026?

Net income attributable to Graham Holdings Company common stockholders was $385.3 million for the nine months ended September 30, 2026, compared with $183.6 million for the same period in 2025.

Did Graham Holdings' pension annuity change retirees' benefit payments?

The insurer is responsible for paying and administering benefits for approximately 1,080 retirees and beneficiaries, with no change to the amount, timing or form of monthly retirement benefit payments. The annuity contract settled $124.3 million of pension obligations and was purchased for $113.9 million using pension-plan assets.

What tax accrual did GHC report alongside the KLG tax benefit?

GHC recorded a $15.3 million Pillar Two top-up income tax accrual and expense for the nine months ended September 30, 2026. The company stated that legislation adopting the Side-by-Side Safe Harbor in the U.K. and other jurisdictions could result in a complete reversal of the accrued amount without payment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
false2026Q3000010488912/3151xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesghc:televisionStationghc:automotiveDealershipghc:schoolsghc:countryghc:businessxbrli:pureiso4217:GBPghc:numberOfRetireesAndBeneficiariesghc:companyghc:investmentghc:claimghc:segment00001048892026-01-012026-09-300000104889us-gaap:CommonClassAMember2026-10-230000104889us-gaap:CommonClassBMember2026-10-230000104889us-gaap:ServiceMember2026-07-012026-09-300000104889us-gaap:ServiceMember2025-07-012025-09-300000104889us-gaap:ServiceMember2026-01-012026-09-300000104889us-gaap:ServiceMember2025-01-012025-09-300000104889us-gaap:ProductMember2026-07-012026-09-300000104889us-gaap:ProductMember2025-07-012025-09-300000104889us-gaap:ProductMember2026-01-012026-09-300000104889us-gaap:ProductMember2025-01-012025-09-3000001048892026-07-012026-09-3000001048892025-07-012025-09-3000001048892025-01-012025-09-3000001048892026-09-3000001048892025-12-3100001048892024-12-3100001048892025-09-300000104889us-gaap:CommonStockMember2025-12-310000104889us-gaap:AdditionalPaidInCapitalMember2025-12-310000104889us-gaap:RetainedEarningsMember2025-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310000104889us-gaap:TreasuryStockCommonMember2025-12-310000104889us-gaap:NoncontrollingInterestMember2025-12-310000104889us-gaap:RetainedEarningsMember2026-01-012026-03-3100001048892026-01-012026-03-310000104889us-gaap:NoncontrollingInterestMember2026-01-012026-03-310000104889us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310000104889us-gaap:TreasuryStockCommonMember2026-01-012026-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310000104889us-gaap:CommonStockMember2026-03-310000104889us-gaap:AdditionalPaidInCapitalMember2026-03-310000104889us-gaap:RetainedEarningsMember2026-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310000104889us-gaap:TreasuryStockCommonMember2026-03-310000104889us-gaap:NoncontrollingInterestMember2026-03-3100001048892026-03-310000104889us-gaap:RetainedEarningsMember2026-04-012026-06-3000001048892026-04-012026-06-300000104889us-gaap:NoncontrollingInterestMember2026-04-012026-06-300000104889us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-300000104889us-gaap:TreasuryStockCommonMember2026-04-012026-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-04-012026-06-300000104889us-gaap:CommonStockMember2026-06-300000104889us-gaap:AdditionalPaidInCapitalMember2026-06-300000104889us-gaap:RetainedEarningsMember2026-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-300000104889us-gaap:TreasuryStockCommonMember2026-06-300000104889us-gaap:NoncontrollingInterestMember2026-06-3000001048892026-06-300000104889us-gaap:RetainedEarningsMember2026-07-012026-09-300000104889us-gaap:NoncontrollingInterestMember2026-07-012026-09-300000104889us-gaap:TreasuryStockCommonMember2026-07-012026-09-300000104889us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-07-012026-09-300000104889us-gaap:CommonStockMember2026-09-300000104889us-gaap:AdditionalPaidInCapitalMember2026-09-300000104889us-gaap:RetainedEarningsMember2026-09-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-09-300000104889us-gaap:TreasuryStockCommonMember2026-09-300000104889us-gaap:NoncontrollingInterestMember2026-09-300000104889us-gaap:CommonStockMember2024-12-310000104889us-gaap:AdditionalPaidInCapitalMember2024-12-310000104889us-gaap:RetainedEarningsMember2024-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000104889us-gaap:TreasuryStockCommonMember2024-12-310000104889us-gaap:NoncontrollingInterestMember2024-12-310000104889us-gaap:RetainedEarningsMember2025-01-012025-03-3100001048892025-01-012025-03-310000104889us-gaap:NoncontrollingInterestMember2025-01-012025-03-310000104889us-gaap:TreasuryStockCommonMember2025-01-012025-03-310000104889us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000104889us-gaap:CommonStockMember2025-03-310000104889us-gaap:AdditionalPaidInCapitalMember2025-03-310000104889us-gaap:RetainedEarningsMember2025-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000104889us-gaap:TreasuryStockCommonMember2025-03-310000104889us-gaap:NoncontrollingInterestMember2025-03-3100001048892025-03-310000104889us-gaap:RetainedEarningsMember2025-04-012025-06-3000001048892025-04-012025-06-300000104889us-gaap:NoncontrollingInterestMember2025-04-012025-06-300000104889us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300000104889us-gaap:TreasuryStockCommonMember2025-04-012025-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300000104889us-gaap:CommonStockMember2025-06-300000104889us-gaap:AdditionalPaidInCapitalMember2025-06-300000104889us-gaap:RetainedEarningsMember2025-06-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300000104889us-gaap:TreasuryStockCommonMember2025-06-300000104889us-gaap:NoncontrollingInterestMember2025-06-3000001048892025-06-300000104889us-gaap:RetainedEarningsMember2025-07-012025-09-300000104889us-gaap:NoncontrollingInterestMember2025-07-012025-09-300000104889us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300000104889us-gaap:TreasuryStockCommonMember2025-07-012025-09-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300000104889us-gaap:CommonStockMember2025-09-300000104889us-gaap:AdditionalPaidInCapitalMember2025-09-300000104889us-gaap:RetainedEarningsMember2025-09-300000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300000104889us-gaap:TreasuryStockCommonMember2025-09-300000104889us-gaap:NoncontrollingInterestMember2025-09-300000104889ghc:TelevisionBroadcastingMember2026-09-300000104889ghc:AutomotiveMember2026-09-300000104889ghc:KaplanLanguagesGroupKLGMember2026-02-010000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2026-03-012026-03-310000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2026-07-012026-07-3100001048892025-01-012025-12-310000104889ghc:EducationMember2025-01-012025-12-310000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2025-01-012025-12-310000104889ghc:ManufacturingMember2025-01-012025-12-310000104889ghc:AutomotiveMember2025-01-012025-12-310000104889ghc:EducationMemberghc:SupplementalEducationMember2025-06-012025-06-300000104889ghc:ManufacturingMemberghc:ArconicArchitecturalProductsLLCMemberghc:HooverTreatedWoodProductsMember2025-07-310000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2025-10-012025-10-310000104889ghc:AutomotiveMemberghc:HondaAutoDealershipMember2025-10-310000104889us-gaap:DelayedDrawTermLoanMemberghc:AutomotiveMemberghc:HondaAutoDealershipMember2025-10-310000104889us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2025-12-310000104889ghc:DublinBusinessSchoolDBSMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2026-09-300000104889ghc:KaplanLanguagesGroupKLGMember2026-04-012026-06-300000104889ghc:KaplanLanguagesGroupKLGMember2026-01-012026-03-310000104889us-gaap:SubsequentEventMemberghc:SkinCliqueMemberghc:SkinCliqueManagementLLCMember2026-10-310000104889us-gaap:SubsequentEventMemberghc:SkinCliqueMember2026-10-012026-10-310000104889us-gaap:SubsequentEventMemberghc:SkinCliqueMemberghc:GrahamHoldingsCompanyMember2026-10-310000104889ghc:CSIPharmacyHoldingCompanyLLCMember2026-07-012026-07-310000104889ghc:CashPaidForCSIMinoritySharesMemberghc:CSIPharmacyHoldingCompanyLLCMember2026-07-012026-07-310000104889ghc:PromissoryNotesForCSIMinoritySharesDue2030Memberghc:CSIPharmacyHoldingCompanyLLCMember2026-07-012026-07-310000104889ghc:PromissoryNotesForCSIMinoritySharesDue2030Memberghc:CSIPharmacyHoldingCompanyLLCMember2026-07-310000104889ghc:CSIPharmacyHoldingCompanyLLCMember2026-03-012026-03-310000104889ghc:CashPaidForCSIMinoritySharesMemberghc:CSIPharmacyHoldingCompanyLLCMember2026-03-012026-03-310000104889ghc:PromissoryNotesForCSIMinoritySharesDue2028Memberghc:CSIPharmacyHoldingCompanyLLCMember2026-03-012026-03-310000104889ghc:PromissoryNotesForCSIMinoritySharesDue2028Memberghc:CSIPharmacyHoldingCompanyLLCMember2026-03-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:GrahamHoldingsCompanyMember2026-09-300000104889ghc:ClarusMember2026-01-012026-01-310000104889ghc:ClarusMemberghc:GrahamHoldingsCompanyMember2026-09-300000104889ghc:ClarusMember2025-10-012025-10-310000104889ghc:ClarusMemberghc:GrahamHoldingsCompanyMember2025-10-310000104889ghc:CSIPharmacyHoldingCompanyLLCMember2025-07-012025-07-310000104889ghc:GHCOneMember2025-02-250000104889ghc:CashPaidToSettleASignificantPortionOfTheMandatorilyRedeemableNoncontrollingInterestMemberghc:GHCOneMember2025-02-250000104889ghc:GHCClassBCommonStockIssuedMemberghc:GHCOneMember2025-02-250000104889ghc:GHCOneMemberus-gaap:SecuritiesSubjectToMandatoryRedemptionMember2025-02-252025-02-250000104889ghc:RemainingGHCOneAndGHCTwoMember2026-09-300000104889ghc:GHCOneMember2026-09-300000104889ghc:CSIPharmacyHoldingCompanyLLCMember2024-12-012024-12-310000104889ghc:CashPaidForCSIMinoritySharesMemberghc:CSIPharmacyHoldingCompanyLLCMember2024-12-012024-12-310000104889ghc:PromissoryNoteForCSIMinoritySharesDue2026Memberghc:CSIPharmacyHoldingCompanyLLCMember2024-12-012024-12-310000104889ghc:PromissoryNoteForCSIMinoritySharesDue2026Memberghc:CSIPharmacyHoldingCompanyLLCMember2024-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:GrahamHoldingsCompanyMember2024-12-310000104889ghc:AdditionalAmountPayableForCSIMinoritySharesMemberghc:CSIPharmacyHoldingCompanyLLCMember2025-12-012025-12-310000104889ghc:AdditionalAmountPayableForCSIMinoritySharesMemberghc:CSIPharmacyHoldingCompanyLLCMember2025-12-310000104889ghc:MarkelGroupIncMember2026-09-300000104889ghc:MarkelGroupIncMember2025-12-310000104889us-gaap:CommonClassAMemberghc:BerkshireHathawayMember2026-09-300000104889us-gaap:CommonClassBMemberghc:BerkshireHathawayMember2026-09-300000104889ghc:BerkshireHathawayMember2026-09-300000104889ghc:ConcentrationInSingleMarketableEquitySecurityMemberus-gaap:AssetsTotalMember2026-01-012026-09-300000104889ghc:HealthcareDivisionMemberghc:MaryFreeBedAtHomeMember2026-09-300000104889ghc:HealthcareDivisionMemberghc:ResidentialHomeHealthIllinoisMember2026-09-300000104889ghc:HealthcareDivisionMemberghc:AlleghenyHealthNetworkHealthcareAtHomeMember2026-09-300000104889ghc:HealthcareDivisionMemberghc:ResidentialHospiceIllinoisMember2026-09-300000104889ghc:HealthcareDivisionMemberus-gaap:RelatedPartyMember2026-07-012026-09-300000104889ghc:HealthcareDivisionMemberus-gaap:RelatedPartyMember2026-01-012026-09-300000104889ghc:HealthcareDivisionMemberus-gaap:RelatedPartyMember2025-07-012025-09-300000104889ghc:HealthcareDivisionMemberus-gaap:RelatedPartyMember2025-01-012025-09-300000104889ghc:N2KNetworksMember2026-09-300000104889ghc:RealmMember2026-09-300000104889ghc:IntersectionMember2026-09-300000104889ghc:N2KNetworksMember2024-05-012024-05-310000104889ghc:RealmMember2026-04-012026-06-300000104889ghc:IntersectionMember2025-09-012025-09-300000104889ghc:IntersectionMember2023-04-012023-04-300000104889ghc:KIHLMemberghc:YorkJointVentureMember2026-09-300000104889ghc:KIHLMemberghc:YorkJointVentureMember2026-01-012026-09-300000104889ghc:AutomotiveMemberghc:VehicleFloorPlanFacilityMember2026-07-012026-09-300000104889ghc:AutomotiveMemberghc:VehicleFloorPlanFacilityMember2026-01-012026-09-300000104889ghc:AutomotiveMemberghc:VehicleFloorPlanFacilityMember2025-07-012025-09-300000104889ghc:AutomotiveMemberghc:VehicleFloorPlanFacilityMember2025-01-012025-09-300000104889ghc:AutomotiveMember2026-07-012026-09-300000104889ghc:AutomotiveMember2025-07-012025-09-300000104889ghc:AutomotiveMember2026-01-012026-09-300000104889ghc:AutomotiveMember2025-01-012025-09-300000104889ghc:AutomotiveMemberghc:VehicleFloorPlanFacilityNewVehiclesMember2026-09-300000104889ghc:AutomotiveMemberghc:VehicleFloorPlanFacilityNewVehiclesMember2025-12-310000104889ghc:EducationMemberghc:KaplanInternationalMember2026-01-012026-03-310000104889ghc:EducationMember2025-12-310000104889ghc:TelevisionBroadcastingMember2025-12-310000104889ghc:HealthcareDivisionMember2025-12-310000104889ghc:ManufacturingMember2025-12-310000104889ghc:AutomotiveMember2025-12-310000104889us-gaap:AllOtherSegmentsMember2025-12-310000104889ghc:EducationMember2026-01-012026-09-300000104889ghc:TelevisionBroadcastingMember2026-01-012026-09-300000104889ghc:HealthcareDivisionMember2026-01-012026-09-300000104889ghc:ManufacturingMember2026-01-012026-09-300000104889us-gaap:AllOtherSegmentsMember2026-01-012026-09-300000104889ghc:EducationMember2026-09-300000104889ghc:HealthcareDivisionMember2026-09-300000104889ghc:ManufacturingMember2026-09-300000104889us-gaap:AllOtherSegmentsMember2026-09-300000104889ghc:EducationAndHealthcareDivisionsMember2026-01-012026-09-300000104889ghc:EducationMemberghc:KaplanInternationalMember2025-12-310000104889ghc:EducationMemberghc:HigherEducationMember2025-12-310000104889ghc:EducationMemberghc:SupplementalEducationMember2025-12-310000104889ghc:HealthcareDivisionMemberghc:CSIPharmacyMember2025-12-310000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2025-12-310000104889ghc:EducationMemberghc:KaplanInternationalMember2026-01-012026-09-300000104889ghc:EducationMemberghc:HigherEducationMember2026-01-012026-09-300000104889ghc:EducationMemberghc:SupplementalEducationMember2026-01-012026-09-300000104889ghc:HealthcareDivisionMemberghc:CSIPharmacyMember2026-01-012026-09-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2026-01-012026-09-300000104889ghc:EducationMemberghc:KaplanInternationalMember2026-09-300000104889ghc:EducationMemberghc:HigherEducationMember2026-09-300000104889ghc:EducationMemberghc:SupplementalEducationMember2026-09-300000104889ghc:HealthcareDivisionMemberghc:CSIPharmacyMember2026-09-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMember2026-09-300000104889srt:MinimumMemberus-gaap:CustomerRelationshipsMember2025-12-310000104889srt:MinimumMemberus-gaap:CustomerRelationshipsMember2026-09-300000104889srt:MaximumMemberus-gaap:CustomerRelationshipsMember2025-12-310000104889srt:MaximumMemberus-gaap:CustomerRelationshipsMember2026-09-300000104889us-gaap:CustomerRelationshipsMember2026-09-300000104889us-gaap:CustomerRelationshipsMember2025-12-310000104889srt:MinimumMemberus-gaap:TrademarksAndTradeNamesMember2025-12-310000104889srt:MinimumMemberus-gaap:TrademarksAndTradeNamesMember2026-09-300000104889srt:MaximumMemberus-gaap:TrademarksAndTradeNamesMember2026-09-300000104889srt:MaximumMemberus-gaap:TrademarksAndTradeNamesMember2025-12-310000104889us-gaap:TrademarksAndTradeNamesMember2026-09-300000104889us-gaap:TrademarksAndTradeNamesMember2025-12-310000104889us-gaap:ContractBasedIntangibleAssetsMember2026-09-300000104889us-gaap:ContractBasedIntangibleAssetsMember2025-12-310000104889srt:MinimumMemberus-gaap:DatabasesMember2026-09-300000104889srt:MinimumMemberus-gaap:DatabasesMember2025-12-310000104889srt:MaximumMemberus-gaap:DatabasesMember2026-09-300000104889srt:MaximumMemberus-gaap:DatabasesMember2025-12-310000104889us-gaap:DatabasesMember2026-09-300000104889us-gaap:DatabasesMember2025-12-310000104889srt:MinimumMemberus-gaap:OtherIntangibleAssetsMember2026-09-300000104889srt:MinimumMemberus-gaap:OtherIntangibleAssetsMember2025-12-310000104889srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2026-09-300000104889srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2025-12-310000104889us-gaap:OtherIntangibleAssetsMember2026-09-300000104889us-gaap:OtherIntangibleAssetsMember2025-12-310000104889us-gaap:FranchiseRightsMember2026-09-300000104889us-gaap:FranchiseRightsMember2025-12-310000104889us-gaap:TrademarksAndTradeNamesMember2026-09-300000104889us-gaap:TrademarksAndTradeNamesMember2025-12-310000104889us-gaap:OperatingAndBroadcastRightsMember2026-09-300000104889us-gaap:OperatingAndBroadcastRightsMember2025-12-310000104889us-gaap:OtherIntangibleAssetsMember2026-09-300000104889us-gaap:OtherIntangibleAssetsMember2025-12-310000104889ghc:FivePointSixTwoFivePercentUnsecuredNotesMaturingIn2033Member2026-09-300000104889ghc:FivePointSixTwoFivePercentUnsecuredNotesMaturingIn2033Member2025-12-310000104889ghc:FiveYearCreditAgreementMaturingIn2030Membersrt:MinimumMember2026-09-300000104889ghc:FiveYearCreditAgreementMaturingIn2030Membersrt:MaximumMember2026-09-300000104889ghc:FiveYearCreditAgreementMaturingIn2030Member2026-09-300000104889ghc:FiveYearCreditAgreementMaturingIn2030Member2025-12-310000104889ghc:RealEstateTermLoanMaturingIn2028Membersrt:MinimumMember2026-09-300000104889ghc:RealEstateTermLoanMaturingIn2028Membersrt:MaximumMember2026-09-300000104889ghc:RealEstateTermLoanMaturingIn2028Member2026-09-300000104889ghc:RealEstateTermLoanMaturingIn2028Member2025-12-310000104889ghc:CapitalTermLoanMaturingIn2028Membersrt:MinimumMember2026-09-300000104889ghc:CapitalTermLoanMaturingIn2028Membersrt:MaximumMember2026-09-300000104889ghc:CapitalTermLoanMaturingIn2028Member2026-09-300000104889ghc:CapitalTermLoanMaturingIn2028Member2025-12-310000104889ghc:OtherIndebtednessMembersrt:MinimumMember2026-09-300000104889ghc:OtherIndebtednessMembersrt:MaximumMember2026-09-300000104889ghc:FivePointSixTwoFivePercentUnsecuredNotesMaturingIn2033Member2025-11-240000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2025-11-242025-11-240000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2025-11-240000104889ghc:TermLoanMaturingIn2027Member2025-11-242025-11-240000104889us-gaap:DelayedDrawTermLoanMemberghc:AutomotiveMember2025-10-210000104889ghc:FiveYearCreditAgreementMaturingIn2030Member2025-11-240000104889ghc:USDRevolvingCreditFacilityBorrowingsMember2026-09-300000104889ghc:USDRevolvingCreditFacilityBorrowingsMemberus-gaap:SecuredOvernightFinancingRateSofrMember2026-01-012026-09-300000104889ghc:GBPRevolvingCreditFacilityBorrowingsMember2026-09-300000104889ghc:GBPRevolvingCreditFacilityBorrowingsMemberghc:SterlingOvernightInterbankAverageRateSONIAMember2026-01-012026-09-300000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMember2026-07-012026-09-300000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMember2026-01-012026-09-300000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMember2025-07-012025-09-300000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMember2025-01-012025-09-300000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2026-09-300000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2026-09-300000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2026-09-300000104889us-gaap:FairValueMeasurementsRecurringMember2026-09-300000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-12-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-12-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-12-310000104889us-gaap:FairValueMeasurementsRecurringMember2025-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2025-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2026-01-012026-09-300000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2026-01-012026-09-300000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2026-09-300000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2026-09-300000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2024-12-310000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2024-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2025-01-012025-09-300000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2025-01-012025-09-300000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2025-09-300000104889ghc:MandatorilyRedeemableNoncontrollingInterestMemberus-gaap:FairValueInputsLevel3Member2025-09-300000104889ghc:GrahamHoldingsCompanyMemberghc:GHCOneAndGHCTwoMember2026-01-012026-09-300000104889ghc:GroupofSeniorManagersofGHGMemberghc:GHCOneAndGHCTwoMember2026-01-012026-09-300000104889ghc:GHCOneAndGHCTwoMemberghc:GrahamHoldingsCompanyMember2026-01-012026-09-300000104889ghc:GHCOneAndGHCTwoMemberghc:GroupofSeniorManagersofGHGMemberghc:GHCOneAndGHCTwoMember2026-09-300000104889ghc:GHCOneAndGHCTwoMemberghc:GroupofSeniorManagersofGHGMember2026-01-012026-09-300000104889ghc:KaplanLanguagesGroupKLGMember2026-01-012026-09-300000104889ghc:KaplanLanguagesGroupKLGMemberus-gaap:DomesticTaxJurisdictionFederalStateAndLocalMember2026-01-012026-09-300000104889ghc:KaplanLanguagesGroupKLGMemberus-gaap:ForeignCountryMember2026-01-012026-09-300000104889ghc:OrganisationForEconomicCoOperationAndDevelopmentOECDPillarTwoMemberghc:KaplanLanguagesGroupKLGMember2026-01-012026-09-300000104889ghc:OrganisationForEconomicCoOperationAndDevelopmentOECDPillarTwoMemberghc:KaplanLanguagesGroupKLGMember2026-09-300000104889country:US2026-07-012026-09-300000104889country:US2026-01-012026-09-300000104889us-gaap:NonUsMember2026-07-012026-09-300000104889us-gaap:NonUsMember2026-01-012026-09-300000104889country:US2025-07-012025-09-300000104889country:US2025-01-012025-09-300000104889us-gaap:NonUsMember2025-07-012025-09-300000104889us-gaap:NonUsMember2025-01-012025-09-300000104889us-gaap:TransferredOverTimeMember2026-07-012026-09-300000104889us-gaap:TransferredOverTimeMember2026-01-012026-09-300000104889us-gaap:TransferredAtPointInTimeMember2026-07-012026-09-300000104889us-gaap:TransferredAtPointInTimeMember2026-01-012026-09-300000104889us-gaap:TransferredOverTimeMember2025-07-012025-09-300000104889us-gaap:TransferredOverTimeMember2025-01-012025-09-300000104889us-gaap:TransferredAtPointInTimeMember2025-07-012025-09-300000104889us-gaap:TransferredAtPointInTimeMember2025-01-012025-09-300000104889ghc:KaplanInternationalMember2026-09-300000104889ghc:KaplanInternationalMember2026-10-01us-gaap:LongTermContractWithCustomerMember2026-09-300000104889ghc:KaplanInternationalMember2025-12-310000104889ghc:AdditionalContractAssetsMember2026-09-300000104889ghc:AdditionalContractAssetsMember2025-12-310000104889ghc:SupplementalEducationMemberus-gaap:LongTermContractWithCustomerMember2026-01-012026-09-300000104889ghc:SupplementalEducationMember2026-10-01us-gaap:LongTermContractWithCustomerMember2026-09-300000104889ghc:SupplementalEducationMemberus-gaap:LongTermContractWithCustomerMember2026-09-300000104889us-gaap:EmployeeStockOptionMember2026-07-012026-09-300000104889us-gaap:EmployeeStockOptionMember2025-07-012025-09-300000104889us-gaap:EmployeeStockOptionMember2026-01-012026-09-300000104889us-gaap:EmployeeStockOptionMember2025-01-012025-09-300000104889us-gaap:CommonClassBMemberus-gaap:RestrictedStockMember2026-07-012026-09-300000104889us-gaap:CommonClassBMemberus-gaap:RestrictedStockMember2025-07-012025-09-300000104889us-gaap:CommonClassBMemberus-gaap:RestrictedStockMember2026-01-012026-09-300000104889us-gaap:CommonClassBMemberus-gaap:RestrictedStockMember2025-01-012025-09-300000104889ghc:ContingentlyIssuableSharesMemberus-gaap:CommonClassBMember2026-01-012026-09-300000104889ghc:ContingentlyIssuableSharesMemberus-gaap:CommonClassBMember2025-01-012025-09-300000104889ghc:ContingentlyIssuableSharesMemberus-gaap:CommonClassBMember2026-07-012026-09-300000104889ghc:ContingentlyIssuableSharesMemberus-gaap:CommonClassBMember2025-07-012025-09-300000104889us-gaap:PensionPlansDefinedBenefitMember2026-01-012026-09-300000104889us-gaap:PensionPlansDefinedBenefitMember2026-07-012026-09-300000104889us-gaap:PensionPlansDefinedBenefitMember2025-07-012025-09-300000104889us-gaap:PensionPlansDefinedBenefitMember2025-01-012025-09-300000104889ghc:IrrevocableGroupAnnuityContractPurchaseMemberus-gaap:PensionPlansDefinedBenefitMember2026-06-012026-06-300000104889ghc:IrrevocableGroupAnnuityContractPurchaseMemberus-gaap:PensionPlansDefinedBenefitMember2026-07-012026-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:KaplanDekkoFramebridgeAndSaatchiArtMemberghc:SeparationIncentiveProgramMember2026-07-012026-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:CorporateOfficeMemberghc:VoluntaryRetirementIncentiveProgramMember2026-07-012026-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:DekkoMemberghc:VoluntaryRetirementIncentiveProgramMember2026-04-012026-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:KaplanGrahamMediaGroupCode3AndSlateMemberghc:SeparationIncentiveProgramMember2026-04-012026-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:KaplanGrahamMediaGroupJoyceDekkoFramebridgeCode3SlateAndCorporateMemberghc:SeparationIncentiveProgramMember2026-01-012026-03-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:KaplanGrahamMediaGroupJoyceSociety6SaatchiArtCode3AndCorporateMemberghc:SeparationIncentiveProgramMember2025-07-012025-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:KaplanGrahamMediaGroupWGBSaatchiArtSociety6Code3AndDecileMemberghc:SeparationIncentiveProgramMember2025-04-012025-06-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:WorldOfGoodBrandsMemberghc:SeparationIncentiveProgramMember2025-01-012025-03-310000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2026-01-012026-09-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2026-07-012026-09-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2025-07-012025-09-300000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2025-01-012025-09-300000104889us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMember2026-09-300000104889us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2026-09-300000104889us-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2026-09-300000104889us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:FixedIncomeSecuritiesUSMemberus-gaap:PensionPlansDefinedBenefitMember2026-09-300000104889ghc:FixedIncomeSecuritiesUSMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:PensionPlansDefinedBenefitMember2026-09-300000104889us-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:AlphabetAndBerkshireHathawayCommonStockMemberghc:InvestmentManager1Member2026-01-012026-09-300000104889ghc:ForeignInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMembersrt:MaximumMemberghc:InvestmentManager1Member2026-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:BerkshireHathawayCommonStockMemberghc:InvestmentManager2Member2026-01-012026-09-300000104889ghc:ForeignInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMembersrt:MaximumMemberghc:InvestmentManager2Member2026-09-300000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2026-01-012026-09-300000104889ghc:ConcentrationInSingleEntityTypeOfIndustryForeignCountryOrIndividualFundMemberghc:DefinedBenefitPlanAssetsTotalMemberus-gaap:PensionPlansDefinedBenefitMember2026-01-012026-09-300000104889ghc:SingleEquityConcentrationMemberus-gaap:EquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2026-09-300000104889ghc:SingleEquityConcentrationMemberus-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2026-09-300000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2026-09-300000104889ghc:SingleEquityConcentrationMemberus-gaap:EquitySecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:SingleEquityConcentrationMemberus-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889ghc:ConcentrationInSingleEntityTypeOfIndustryForeignCountryOrIndividualFundMemberghc:DefinedBenefitPlanAssetsTotalMemberus-gaap:PensionPlansDefinedBenefitMember2025-01-012025-12-310000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2025-12-310000104889us-gaap:PensionPlansDefinedBenefitMemberghc:MarkelGroupIncMember2026-09-300000104889us-gaap:PensionPlansDefinedBenefitMemberghc:MarkelGroupIncMember2025-12-310000104889ghc:KaplanLanguagesGroupKLGMemberghc:EducationMember2026-04-012026-06-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2026-07-012026-09-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2025-07-012025-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2026-07-012026-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2025-07-012025-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2026-07-012026-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2025-07-012025-09-300000104889ghc:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainsIncludedInNetIncomeMember2026-07-012026-09-300000104889ghc:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainsIncludedInNetIncomeMember2025-07-012025-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-07-012026-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-07-012025-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-07-012026-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-07-012025-09-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2026-01-012026-09-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2026-01-012026-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2025-01-012025-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2026-01-012026-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2025-01-012025-09-300000104889ghc:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainsIncludedInNetIncomeMember2026-01-012026-09-300000104889ghc:AccumulatedDefinedBenefitPlansAdjustmentSettlementGainsIncludedInNetIncomeMember2025-01-012025-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-01-012026-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-01-012026-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-01-012025-09-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2025-12-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-12-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2026-01-012026-09-300000104889us-gaap:AccumulatedTranslationAdjustmentMember2026-09-300000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2026-09-300000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-09-300000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2026-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2026-07-012026-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2025-07-012025-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2026-01-012026-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-07-012026-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-07-012025-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-01-012026-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-01-012025-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2026-07-012026-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2026-01-012026-09-300000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-300000104889srt:MaximumMember2026-09-300000104889ghc:EducationMemberghc:PurdueUniversityGlobalMemberghc:HigherEducationMember2026-09-300000104889ghc:KaplanUniversityTransactionMemberghc:EducationMemberghc:PurdueUniversityGlobalMemberghc:HigherEducationMember2018-03-222018-03-220000104889ghc:KaplanUniversityTransactionMemberghc:EducationMemberghc:PurdueUniversityGlobalMemberghc:HigherEducationMember2026-01-012026-09-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889ghc:TelevisionBroadcastingMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889ghc:HealthcareDivisionMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889ghc:ManufacturingMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889ghc:AutomotiveMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889us-gaap:CorporateAndOtherMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889us-gaap:IntersegmentEliminationMember2026-07-012026-09-300000104889us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889us-gaap:CorporateNonSegmentMember2026-07-012026-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889ghc:EducationMemberus-gaap:IntersubsegmentEliminationsMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2026-07-012026-09-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889ghc:TelevisionBroadcastingMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889ghc:HealthcareDivisionMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889ghc:ManufacturingMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889ghc:AutomotiveMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889us-gaap:CorporateAndOtherMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889us-gaap:IntersegmentEliminationMember2025-07-012025-09-300000104889us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889us-gaap:CorporateNonSegmentMember2025-07-012025-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889ghc:EducationMemberus-gaap:IntersubsegmentEliminationsMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2025-07-012025-09-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889ghc:TelevisionBroadcastingMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889ghc:HealthcareDivisionMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889ghc:ManufacturingMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889ghc:AutomotiveMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889us-gaap:CorporateAndOtherMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889us-gaap:IntersegmentEliminationMember2026-01-012026-09-300000104889us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889us-gaap:CorporateNonSegmentMember2026-01-012026-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889ghc:EducationMemberus-gaap:IntersubsegmentEliminationsMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2026-01-012026-09-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889ghc:TelevisionBroadcastingMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889ghc:HealthcareDivisionMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889ghc:ManufacturingMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889ghc:AutomotiveMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889us-gaap:CorporateAndOtherMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889us-gaap:IntersegmentEliminationMember2025-01-012025-09-300000104889us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889us-gaap:CorporateNonSegmentMember2025-01-012025-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889ghc:EducationMemberus-gaap:IntersubsegmentEliminationsMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2025-01-012025-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2026-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:KaplanInternationalMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2026-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2026-09-300000104889ghc:EducationMemberus-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2026-09-300000104889ghc:EducationMemberghc:KaplanCorporateAndOtherMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2026-09-300000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:TelevisionBroadcastingMemberus-gaap:OperatingSegmentsMember2026-09-300000104889ghc:TelevisionBroadcastingMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2026-09-300000104889ghc:HealthcareDivisionMemberus-gaap:ReportableSubsegmentsMemberghc:CSIPharmacyMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2026-09-300000104889ghc:HealthcareDivisionMemberghc:OtherHealthcareMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:HealthcareDivisionMemberus-gaap:OperatingSegmentsMember2026-09-300000104889ghc:HealthcareDivisionMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:ManufacturingMemberus-gaap:OperatingSegmentsMember2026-09-300000104889ghc:ManufacturingMemberus-gaap:OperatingSegmentsMember2025-12-310000104889ghc:AutomotiveMemberus-gaap:OperatingSegmentsMember2026-09-300000104889ghc:AutomotiveMemberus-gaap:OperatingSegmentsMember2025-12-310000104889us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMemberus-gaap:OperatingSegmentsMember2026-09-300000104889us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMemberus-gaap:OperatingSegmentsMember2025-12-310000104889us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2026-09-300000104889us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2025-12-310000104889us-gaap:CorporateNonSegmentMember2026-09-300000104889us-gaap:CorporateNonSegmentMember2025-12-310000104889ghc:MarcelA.SnymanMember2026-01-012026-09-300000104889ghc:MarcelA.SnymanMember2026-07-012026-09-300000104889ghc:MarcelA.SnymanMember2026-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
☒
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended September 30, 2026
or
☐
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission File Number 001-06714
GRAHAM HOLDINGS COMPANY
(Exact name of registrant as specified in its charter)
Delaware53-0182885
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1812 North Moore Street, Arlington, Virginia

22209
(Address of principal executive offices)(Zip Code)
(703) 345-6300
(Registrant’s telephone number, including area code)
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class B Common Stock, par value $1.00 per share GHCNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  ☒.    No  ☐.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  ☒.    No  ☐.  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
☒
Accelerated
filer
☐Non-accelerated
filer
☐Smaller reporting
company
☐Emerging growth
company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐.    No  ☒.  
Shares outstanding at October 23, 2026:
Class A Common Stock – 964,001 Shares
Class B Common Stock – 3,204,785 Shares



GRAHAM HOLDINGS COMPANY
Index to Form 10-Q
 
PART I. FINANCIAL INFORMATION
 
Item 1.
Financial Statements
 
 
Condensed Consolidated Statements of Operations
1
 
 
 
 
Condensed Consolidated Statements of Comprehensive Income
2
 
 
 
 
Condensed Consolidated Balance Sheets
3
 
 
 
 
Condensed Consolidated Statements of Cash Flows
4
Condensed Consolidated Statements of Changes in Common Stockholders' Equity
5
 
 
 
 
Notes to Condensed Consolidated Financial Statements
7

Organization, Basis of Presentation and Recent Accounting Pronouncements
7

Acquisitions and Dispositions of Businesses
8

Investments
11

Accounts Receivable, Accounts Payable, Vehicle Floor Plan Payable and Accrued Liabilities
12

Inventories and Contracts in Progress
13

Goodwill and Other Intangible Assets
13

Debt
15

Fair Value Measurements
17

Income Taxes
19

Revenue From Contracts With Customers
19

Earnings Per Share
20

Pension Plans
22

Other Non-Operating (Expense) Income
23

Accumulated Other Comprehensive Income (Loss)
24

Contingencies
25

Business Segments
25
Item 2.
Management’s Discussion and Analysis of Results of Operations and Financial Condition
35
 
 
 
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
48
 
 
 
Item 4.
Controls and Procedures
48
 
 
PART II. OTHER INFORMATION
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
49
Item 5.
Other Information
49
Item 6.
Exhibits
50
 
 
Signatures
51



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
  Three Months Ended 
 September 30
Nine Months Ended 
 September 30
  
(in thousands, except per share amounts)2026202520262025
Operating Revenues
Sales of services$659,733 $700,356 $1,998,097 $2,016,490 
Sales of goods666,304 578,503 1,866,438 1,644,056 
1,326,037 1,278,859 3,864,535 3,660,546 
Operating Costs and Expenses    
Cost of services sold (exclusive of items shown below)385,736 425,051 1,165,725 1,200,503 
Cost of goods sold (exclusive of items shown below)548,050 479,344 1,535,736 1,362,688 
Selling, general and administrative282,836 276,103 844,455 823,499 
Depreciation of property, plant and equipment18,119 19,298 54,794 59,504 
Amortization of intangible assets5,775 9,692 17,808 24,757 
Impairment of goodwill, other long-lived assets and asset group held for sale— 2,235 19,029 2,235 
  1,240,516 1,211,723 3,637,547 3,473,186 
Income from Operations
85,521 67,136 226,988 187,360 
Equity in (losses) earnings of affiliates, net
(3,590)15,780 11,397 10,466 
Interest income1,594 1,464 5,950 6,225 
Interest expense(15,769)(17,164)(49,171)(117,547)
Non-operating pension and postretirement benefit income, net47,601 31,047 248,323 94,266 
(Loss) gain on marketable equity securities, net
(15,027)84,768 17,929 117,026 
Other (expense) income, net(1,187)7 (4,146)(20,514)
Income Before Income Taxes
99,143 183,038 457,270 277,282 
Provision for Income Taxes
21,900 56,800 66,900 84,900 
Net Income
77,243 126,238 390,370 192,382 
Net Income Attributable to Noncontrolling Interests(2,133)(3,313)(5,051)(8,814)
Net Income Attributable to Graham Holdings Company Common Stockholders
$75,110 $122,925 $385,319 $183,568 
Per Share Information Attributable to Graham Holdings Company Common Stockholders
      
Basic net income per common share
$17.79 $28.19 $89.84 $42.15 
Basic average number of common shares outstanding4,198 4,334 4,264 4,329 
Diluted net income per common share
$17.60 $27.91 $88.92 $41.75 
Diluted average number of common shares outstanding4,243 4,378 4,309 4,370 
See accompanying Notes to Condensed Consolidated Financial Statements.
1


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
  Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands)2026202520262025
Net Income$77,243 $126,238 $390,370 $192,382 
Other Comprehensive Income (Loss), Before Tax      
Foreign currency translation adjustments:      
Translation adjustments arising during the period3,309 (8,227)(2,814)38,323 
Adjustment for sales of businesses with foreign operations— — 6,175 646 
3,309 (8,227)3,361 38,969 
Pension and other postretirement plans:        
Actuarial gain (loss)45,115 — (44,813)— 
Amortization of net prior service credit included in net income(496)(520)(1,489)(1,560)
Amortization of net actuarial gain included in net income
(258)(378)(774)(1,137)
Settlement gain included in net income(14,950)— (151,905)— 
  29,411 (898)(198,981)(2,697)
Cash flow hedges gain (loss)970 64 2,236 (979)
Other Comprehensive Income (Loss), Before Tax33,690 (9,061)(193,384)35,293 
Income tax (expense) benefit related to items of other comprehensive income (loss)(7,902)212 51,181 944 
Other Comprehensive Income (Loss), Net of Tax25,788 (8,849)(142,203)36,237 
Comprehensive Income103,031 117,389 248,167 228,619 
Comprehensive income attributable to noncontrolling interests
(2,133)(3,313)(5,051)(8,814)
Total Comprehensive Income Attributable to Graham Holdings Company$100,898 $114,076 $243,116 $219,805 

See accompanying Notes to Condensed Consolidated Financial Statements.
2


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS
As of
(in thousands)September 30,
2026
December 31,
2025
  (Unaudited)  
Assets
Current Assets
Cash and cash equivalents$154,326 $266,988 
Restricted cash17,756 44,417 
Investments in marketable equity securities and other investments1,074,071 1,088,970 
Accounts receivable, net537,651 576,754 
Inventories and contracts in progress354,457 303,370 
Prepaid expenses115,171 124,875 
Income taxes receivable33,375 15,447 
Other current assets12,672 10,274 
Current assets held for sale (includes $24,786 of cash and $19,178 of restricted cash)
57,844 — 
Total Current Assets2,357,323 2,431,095 
Property, Plant and Equipment, Net596,153 587,434 
Lease Right-of-Use Assets382,275 404,818 
Investments in Affiliates202,339 229,565 
Goodwill, Net1,551,393 1,585,666 
Indefinite-Lived Intangible Assets170,339 170,805 
Amortized Intangible Assets, Net43,635 61,631 
Prepaid Pension Cost2,789,352 2,772,394 
Deferred Income Taxes9,125 9,690 
Deferred Charges and Other Assets125,741 142,615 
Noncurrent Assets Held for Sale62,324 — 
Total Assets$8,289,999 $8,395,713 
Liabilities and Equity
Current Liabilities
Accounts payable, vehicle floor plan payable and accrued liabilities$691,474 $721,626 
Deferred revenue352,558 411,651 
Income taxes payable25,949 8,995 
Mandatorily redeemable noncontrolling interest6,033 6,874 
Current portion of lease liabilities59,023 64,290 
Current portion of long-term debt148,075 175,138 
Dividends declared7,869 — 
Current liabilities held for sale49,061 — 
Total Current Liabilities1,340,042 1,388,574 
Accrued Compensation and Related Benefits140,209 135,323 
Other Liabilities29,129 28,639 
Deferred Income Taxes867,497 890,984 
Mandatorily Redeemable Noncontrolling Interest1,240 1,527 
Lease Liabilities365,829 377,897 
Long-Term Debt705,359 705,618 
Noncurrent Liabilities Held for Sale3,037 — 
Total Liabilities3,452,342 3,528,562 
Commitments and Contingencies (Note 15)
Redeemable Noncontrolling Interests25,469 39,824 
Preferred Stock— — 
Common Stockholders’ Equity
Common stock20,000 20,000 
Capital in excess of par value354,197 379,896 
Retained earnings8,645,846 8,292,681 
Accumulated other comprehensive income, net of taxes  
Cumulative foreign currency translation adjustment(8,901)(12,262)
Unrealized gain on pensions and other postretirement plans453,843 601,064 
Cash flow hedges(65)(1,722)
Cost of Class B common stock held in treasury(4,686,844)(4,485,632)
Total Common Stockholders’ Equity4,778,076 4,794,025 
Noncontrolling Interests34,112 33,302 
Total Equity4,812,188 4,827,327 
Total Liabilities and Equity$8,289,999 $8,395,713 
See accompanying Notes to Condensed Consolidated Financial Statements.
3


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
  Nine Months Ended 
 September 30
(in thousands)20262025
Cash Flows from Operating Activities    
Net Income$390,370 $192,382 
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and goodwill and other asset impairments91,631 86,496 
Amortization of lease right-of-use asset43,707 44,229 
Net pension benefit, settlement gain and early retirement and special separation benefit expense(215,165)(61,090)
Gain on marketable equity securities and cost method investments, net of impairment(17,829)(102,861)
Loss on disposition of businesses, property, plant and equipment and investments, net3,011 1,019 
Credit loss expense4,726 2,921 
Stock-based compensation expense, net of forfeitures4,467 4,797 
Foreign exchange loss2,034 7,707 
Equity in (earnings) losses of affiliates, net of distributions26,235 (2,562)
Provision for deferred income taxes24,888 28,578 
Change in operating assets and liabilities:
Accounts receivable4,661 13,083 
Inventories(44,177)22,682 
Accounts payable and accrued liabilities(8,289)31,249 
Deferred revenue(3,570)14,382 
Income taxes receivable/payable(2,545)5,455 
Lease liabilities(38,557)(41,722)
Other assets and other liabilities, net13,280 71,708 
Other1,954 443 
Net Cash Provided by Operating Activities280,832 318,896 
Cash Flows from Investing Activities    
Purchases of property, plant and equipment(65,013)(48,618)
Proceeds from sales of marketable equity securities54,642 — 
Net (payment on) proceeds from disposition of businesses, property, plant and equipment and investments(37,900)7,747 
Purchases of marketable equity securities(25,020)(29,823)
Proceeds from repayment of related party loan20,000 — 
Investments in certain businesses, net of cash acquired(18,362)(19,486)
Investments in equity affiliates and cost method investments(204)(10,512)
Other 2,136 2,330 
Net Cash Used in Investing Activities(69,721)(98,362)
Cash Flows from Financing Activities    
Common shares repurchased(198,598)(3,468)
Net (payments) borrowings under revolving credit facilities(31,258)600 
Dividends paid(24,285)(23,508)
Repayments of borrowings(21,535)(22,089)
Purchase of noncontrolling interests(17,526)(1,761)
Principal payments of finance leases(13,406)(13,049)
Distributions paid to noncontrolling interests(5,269)(191,609)
Net proceeds from (repayments of) vehicle floor plan payable4,863 (27,897)
Issuance of borrowings1,800 — 
Deferred payments of acquisitions(383)(7,017)
Other988 (1,019)
Net Cash Used in Financing Activities(304,609)(290,817)
Effect of Currency Exchange Rate Change(1,861)9,533 
Net Decrease in Cash and Cash Equivalents and Restricted Cash(95,359)(60,750)
Beginning Cash and Cash Equivalents and Restricted Cash311,405 297,853 
Ending Cash and Cash Equivalents and Restricted Cash$216,046 $237,103 


See accompanying Notes to Condensed Consolidated Financial Statements.
4


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN COMMON STOCKHOLDERS’ EQUITY (UNAUDITED)
(in thousands)Common
Stock
Capital in
Excess of
Par Value
Retained
Earnings
Accumulated Other Comprehensive IncomeTreasury
Stock
Noncontrolling
Interest
Total EquityRedeemable Noncontrolling Interest
As of December 31, 2025$20,000 $379,896 $8,292,681 $587,080 $(4,485,632)$33,302 $4,827,327 $39,824 
Net income for the period30,751 30,751 
Net income attributable to noncontrolling interests(699)699 — 
Net income attributable to redeemable noncontrolling interests(946)(946)946 
Change in redemption value of redeemable noncontrolling interest(8,225)(4)(8,229)8,250 
Distributions to noncontrolling interests(884)(884)(2,251)
Dividends on common stock(16,398)(16,398)
Repurchase of Class B common stock(34,476)(34,476)
Issuance of Class B common stock, net of restricted stock award forfeitures(252)224 (28)
Shares withheld related to net share settlement(434)(434)
Amortization of unearned stock compensation and stock option expense1,525 1,525 
Purchase of noncontrolling interest(26,001)939(25,062)
Other comprehensive loss, net of income taxes(6,342)(6,342)
Purchase of redeemable noncontrolling interests— (16,849)
As of March 31, 2026$20,000 $346,943 $8,305,389 $580,738 $(4,520,318)$34,052 $4,766,804 $29,920 
Net income for the period282,376 282,376 
Net income attributable to noncontrolling interests(1,348)1,348 — 
Net loss attributable to redeemable noncontrolling interests75 75 (75)
Change in redemption value of redeemable noncontrolling interests4,427 210 4,637 (4,427)
Distributions to noncontrolling interests(1,088)(1,088)(32)
Dividends on common stock(7,953)(7,953)
Repurchase of Class B common stock(88,718)(88,718)
Issuance of Class B common stock, net of restricted stock award forfeitures(160)3 (157)
Amortization of unearned stock compensation and stock option expense1,773 1,773 
Other comprehensive loss, net of income taxes(161,649)(161,649)
As of June 30, 2026$20,000 $352,983 $8,578,539 $419,089 $(4,609,033)$34,522 $4,796,100 $25,386 
Net income for the period77,243 77,243 
Net income attributable to noncontrolling interests(1,550)1,550 — 
Net income attributable to redeemable noncontrolling interests(583)(583)583 
Change in redemption value of redeemable noncontrolling interests15 15 
Noncontrolling interest capital contribution279 279 
Distributions to noncontrolling interests(389)(389)(500)
Dividends on common stock(7,803)(7,803)
Repurchase of Class B common stock(77,371)(77,371)
Issuance of Class B common stock, net of restricted stock award forfeitures(179)141 (38)
Shares withheld related to net share settlement(581)(581)
Amortization of unearned stock compensation and stock option expense1,393 1,393 
Purchase of noncontrolling interest(1,865)(1,865)
Other comprehensive income, net of income taxes25,788 25,788 
As of September 30, 2026$20,000 $354,197 $8,645,846 $444,877 $(4,686,844)$34,112 $4,812,188 $25,469 
5


(in thousands)Common
Stock
Capital in
Excess of
Par Value
Retained
Earnings
Accumulated Other Comprehensive IncomeTreasury
Stock
Noncontrolling
Interest
Total EquityRedeemable Noncontrolling Interest
As of December 31, 2024$20,000 $356,919 $8,031,750 $334,797 $(4,486,805)$30,154 $4,286,815 $43,821 
Net income for the period25,721 25,721 
Net income attributable to noncontrolling interests
(1,129)1,129 — 
Net income attributable to redeemable noncontrolling interests
(698)(698)698 
Change in redemption value of redeemable noncontrolling interests634 634 8 
Noncontrolling interest capital contribution180 180 
Distributions to noncontrolling interests(747)(747)(941)
Dividends on common stock(15,662)(15,662)
Repurchase of Class B common stock(3,468)(3,468)
Issuance of Class B common stock, net of restricted stock award forfeitures9,431 9,141 18,572 
Shares withheld related to net share settlement(402)(402)
Amortization of unearned stock compensation and stock option expense1,724 1,724 
Other comprehensive income, net of income taxes13,096 13,096 
As of March 31, 2025$20,000 $368,074 $8,039,982 $347,893 $(4,481,534)$31,350 $4,325,765 $43,586 
Net income for the period40,423 40,423 
Net income attributable to noncontrolling interests
(2,030)2,030 — 
Net income attributable to redeemable noncontrolling interests
(1,644)(1,644)1,644 
Change in redemption value of redeemable noncontrolling interests
(4,971)642 (4,329)4,977 
Distributions to noncontrolling interests(1,371)(1,371)(338)
Dividends on common stock(7,846)(7,846)
Forfeiture of restricted stock awards, net of Class B common stock issuances(6)(124)(130)
Amortization of unearned stock compensation and stock option expense
1,696 1,696 
Other comprehensive income, net of income taxes31,990 31,990 
As of June 30, 2025$20,000 $364,793 $8,068,885 $379,883 $(4,481,658)$32,651 $4,384,554 $49,869 
Net income for the period126,238 126,238 
Net income attributable to noncontrolling interests(1,652)1,652 — 
Net income attributable to redeemable noncontrolling interests(1,661)(1,661)1,661 
Change in redemption value of redeemable noncontrolling interests(852)264 (588)859 
Distributions to noncontrolling interests(872)(872)(371)
Dividends on common stock(7,852)(7,852)
Issuance of Class B common stock(32)32 — 
Shares withheld related to net share settlement(2,235)(2,235)
Amortization of unearned stock compensation and stock option expense1,686 1,686 
Purchase of noncontrolling interest(1,761)(1,761)
Other comprehensive loss, net of income taxes(8,849)(8,849)
As of September 30, 2025$20,000 $365,595 $8,183,958 $371,034 $(4,483,861)$31,934 $4,488,660 $52,018 


See accompanying Notes to Condensed Consolidated Financial Statements.
6


GRAHAM HOLDINGS COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. ORGANIZATION, BASIS OF PRESENTATION AND RECENT ACCOUNTING PRONOUNCEMENTS
Graham Holdings Company (the Company), is a diversified holding company whose operations include educational services, television broadcasting, healthcare, manufacturing, automotive dealerships and other businesses.
Through Kaplan, Inc. (Kaplan), the Company provides a wide variety of educational services to students, schools, colleges, universities and businesses, both domestically and outside the United States (U.S.). Kaplan’s educational services include academic preparation programs for international students; operations support services for pre-college, certificate, undergraduate and graduate programs; exam preparation for high school and graduate students and for professional certifications and licensures; career and academic advisement services to businesses; and a United Kingdom (U.K.) sixth-form college that prepares students for A-level examinations.
The Company’s television broadcasting segment owns and operates seven television broadcasting stations and provides social media management tools designed to connect newsrooms with their users.

The Company’s healthcare division provides in-home specialty pharmacy infusion therapies; home health, hospice and palliative services; physician services for allergy, asthma and immunology patients; in-home aesthetics; applied behavior analysis therapy; and healthcare software-as-a-service technology.
The Company’s manufacturing companies include a supplier of pressure-treated wood and aluminum cladding products, a manufacturer of electrical solutions, a manufacturer of lifting solutions, and a supplier of parts used in electric utilities and industrial systems.
The Company’s automotive business comprises eight dealerships and valet repair services.
The Company’s other businesses include restaurants; a custom framing company; a marketing solutions provider; a customer data and analytics software company; Slate and Foreign Policy magazines; a daily local news podcast and newsletter company; a company that provides a software-as-a-service platform that enables podcasters and media companies to monetize audio content through paid subscriptions, memberships, and audiobooks; an online art gallery and in-person art fair business; and an online commerce platform featuring original art and designs on an array of consumer products.
On February 1, 2026, Kaplan entered into a Share Purchase Agreement to sell its Kaplan Languages Group (KLG) business, consisting of more than 20 language schools in eight countries. The transaction closed on May 1, 2026.
In the third quarter of 2026, Kaplan entered into a Share Purchase Agreement to sell Dublin Business School (DBS). The transaction closed on October 27, 2026.
Basis of Presentation – The accompanying condensed consolidated financial statements have been prepared in accordance with: (i) generally accepted accounting principles in the United States of America (GAAP) for interim financial information; (ii) the instructions to Form 10-Q; and (iii) the guidance of Rule 10-01 of Regulation S-X under the Securities and Exchange Act of 1934, as amended, for financial statements required to be filed with the Securities and Exchange Commission (SEC). They include the assets, liabilities, results of operations and cash flows of the Company, including its domestic and foreign subsidiaries that are more than 50% owned or otherwise controlled by the Company. As permitted under such rules, certain notes and other financial information normally required by GAAP have been condensed or omitted. Management believes the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments necessary for a fair statement of the Company’s financial position, results of operations, and cash flows as of and for the periods presented herein. The Company’s results of operations for the three and nine months ended September 30, 2026 and 2025 may not be indicative of the Company’s future results. These condensed consolidated financial statements are unaudited and should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.
Use of Estimates in the Preparation of the Condensed Consolidated Financial Statements – The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported herein. Management bases its estimates and assumptions on historical experience and on various other factors that are believed to be reasonable under the
7


circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in those estimates.
Assets Held for Sale – An asset or business is classified as held for sale when (i) management commits to a plan to sell the asset or business; (ii) the asset or business is available for immediate sale in its present condition; (iii) the asset or business is actively marketed for sale at a reasonable price; (iv) the sale is expected to be completed within one year; and (v) it is unlikely significant changes to the plan will be made or that the plan will be withdrawn. The assets and related liabilities are aggregated and reported separately in the Company’s Condensed Consolidated Financial Statements (see Note 2).
Recently Adopted and Issued Accounting Pronouncements – In November 2024, the Financial Accounting Standards Board (FASB) issued new guidance that requires disclosures about certain significant expense categories including inventory purchases, employee compensation, depreciation, amortization, and selling expenses. The guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is in the process of evaluating the impact of this new guidance on the disclosures within its Condensed Consolidated Financial Statements.
In September 2025, FASB issued new guidance which updates the accounting for internal-use software by removing references to software development project stages and adding new criteria to determine when an entity is required to start capitalizing internal-use software costs. The guidance is effective for fiscal years and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is in the process of evaluating the impact of this new guidance on its Condensed Consolidated Financial Statements.
2. ACQUISITIONS AND DISPOSITIONS OF BUSINESSES
Acquisitions. During the first nine months of 2026, the Company acquired two small businesses, one in March and one in July, both of which are included in other healthcare businesses. The assets and liabilities of the companies acquired were recorded at their estimated fair values at the date of acquisition.
During 2025, the Company acquired five businesses: one in education, two in other healthcare businesses, one in manufacturing and one in automotive for $71.2 million in cash and the assumption of floor plan payables and $107.5 million in net pension obligations. The assets and liabilities of the companies acquired were recorded at their estimated fair values at the date of acquisition.
In June 2025, Kaplan acquired one small business which is included in its supplemental education division.
In July 2025, Hoover acquired 100% of Arconic Architectural Products, LLC, a wholly-owned subsidiary of Arconic Corporation, which manufactures aluminum cladding products and operates within the broader non-residential materials space from its facility in Eastman, GA. A significant portion of the purchase price was funded by the Company’s assumption of certain pension obligations. The acquisition expands Hoover’s product offerings and is included in manufacturing.
In October 2025, Graham Healthcare Group (GHG) acquired two small businesses which are included in other healthcare businesses.
In October 2025, the Company’s automotive subsidiary acquired a Honda automotive dealership, including the real property for the dealership operations. In addition to a cash payment and the assumption of $4.9 million in floor plan payables, the automotive subsidiary borrowed $38.7 million under the delayed draw term loan to finance the acquisition (see Note 7). The dealership is operated and managed by an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships. This acquisition expands the Company’s automotive business operations and is included in automotive.
8


Acquisition-related costs for the acquisitions that closed during the first nine months of 2025 were $2.0 million and expensed as incurred. The aggregate purchase price of the 2025 acquisitions was allocated as follows, based on the acquisition date fair values to the following assets and liabilities:
Purchase Price Allocation
Year Ended
(in thousands)December 31, 2025
Accounts receivable$11,641 
Inventory32,731 
Property, plant and equipment35,920 
Lease right-of-use assets3,642 
Goodwill51,943 
Indefinite-lived intangible assets15,500 
Amortized intangible assets41,300 
Deferred income taxes13,947 
Other assets221 
Pension liabilities(107,517)
Floor plan payables(4,939)
Other liabilities(18,371)
Current and noncurrent lease liabilities(4,783)
Aggregate purchase price, net of cash acquired$71,235 
Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The goodwill recorded due to these acquisitions is attributable to the assembled workforces of the acquired companies and expected synergies. The Company expects to deduct $12.4 million of goodwill for income tax purposes for the acquisitions completed in 2025.
The acquired companies were consolidated into the Company’s financial statements starting on their respective acquisition dates. The following unaudited pro forma financial information includes the 2025 acquisitions as if they occurred at the beginning of 2024:
Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands)20252025
Operating revenues$1,305,382 $3,782,022 
Net income129,979 199,322 
These pro forma results were based on estimates and assumptions, which the Company believes are reasonable, and include the historical results of operations of the acquired companies and adjustments for depreciation and amortization of identified assets and the effect of pre-acquisition transaction related expenses incurred by the Company and the acquired entities. The pro forma information does not include efficiencies, cost reductions and synergies expected to result from the acquisitions. They are not the results that would have been realized had these entities been part of the Company during the periods presented and are not necessarily indicative of the Company’s consolidated results of operations in future periods.
Disposition of Businesses. During the third quarter of 2026, Kaplan entered into a Share Purchase Agreement to sell the DBS business, which is included in Kaplan International. As a result, the Company classified the assets and liabilities of DBS as held for sale in the Company’s Condensed Consolidated Balance Sheet as of September 30, 2026. The transaction closed on October 27, 2026.
9


The carrying amounts of the major classes of assets and liabilities of the DBS disposal group classified as held for sale as of September 30, 2026 are as follows:
As of
(in thousands)September 30, 2026
Cash and cash equivalents$24,786 
Restricted cash19,178 
Accounts receivable, net6,843 
Prepaid expenses6,384 
Other current assets653 
Current Assets Held for Sale$57,844 
Property, plant and equipment, net$3,403 
Lease right-of-use assets5,536 
Goodwill, net51,786 
Deferred charges and other assets1,599 
Noncurrent Assets Held for Sale$62,324 
Accounts payable and accrued liabilities$22,868 
Deferred revenue25,128 
Income taxes payable(1,067)
Current portion of lease liabilities2,132 
Current Liabilities Held for Sale$49,061 
Other liabilities$442 
Deferred income taxes(843)
Lease liabilities3,438 
Noncurrent Liabilities Held for Sale$3,037 
In May 2026, Kaplan completed the sale of the KLG business, which is included in Kaplan International. As a result of the sale, the Company recorded a non-operating loss of $5.2 million in the second quarter of 2026 (see Note 13). KLG comprised Kaplan International Languages, Alpadia Language Schools, Azurlingua and English as a second language (ESL) Education. The assets and liabilities of KLG had previously been classified as held for sale in the Company’s Condensed Consolidated Balance Sheet as of March 31, 2026.
During the first quarter of 2026, upon classifying the KLG disposal group as held for sale, the Company recognized total impairment charges of $19.0 million, consisting of a $1.0 million goodwill impairment charge and an $18.0 million impairment charge related to the asset group held for sale.
In early September 2025, the Company ceased operations of the Ourisman Jeep of Bethesda dealership.
In April 2025, Kaplan completed the sale of a small business, BridgeU Limited, which was included in Kaplan International.
In the first half of 2025, World of Good Brands (WGB) completed the sale of various websites and related businesses that made up the WGB operations, which were included in other businesses. All remaining WGB operations were substantially shut down by the end of the third quarter of 2025.
Other Transactions. In October 2026, the Company acquired the 49% minority-owned shares of Skin Clique for $18.4 million; the Company now owns 100% of Skin Clique.
In July 2026, CSI Pharmacy Holding Company, LLC (CSI) exercised its call option to purchase some of the minority-owned interest of CSI for $1.9 million. CSI paid cash of $0.2 million and entered into promissory notes for the remaining $1.7 million with an interest rate of 5.5% per annum. The notes are included in other indebtedness (see Note 7) and payable in annual installments with the final payment due July 31, 2030.
In March 2026, the Company acquired some of the minority-owned shares of CSI for a total amount of $41.0 million. The Company paid cash of $16.4 million and entered into promissory notes with the minority owners for the remaining $24.6 million at an interest rate of 8% per annum. The notes are included in other indebtedness (see Note 7) and payable in quarterly installments with the final payment due on April 1, 2028. Following the redemption, the Company owns 93.4% of CSI.
In January 2026, pursuant to the exercise of a put right, the Company purchased some of the minority-owned interest of Clarus for $1.0 million. Following the redemption, the Company owns 97.5% of Clarus.
10


In October 2025, pursuant to the exercise of a put right, the Company purchased some of the minority-owned interest of Clarus for $0.4 million. Following the redemption, the Company owned 95.75% of Clarus.
In July 2025, CSI exercised its call option to purchase some of the minority-owned interest of CSI for $1.8 million.
On February 25, 2025, the Company and a group of minority shareholders entered into an agreement to settle a significant portion of the mandatorily redeemable noncontrolling interest related to GHC One LLC (GHC One), including CSI, for a total of $205 million, which consisted of approximately $186.25 million in cash and $18.75 million in Graham Holdings Company Class B common stock.
The settlement agreement resulted in a $66.2 million increase to the mandatorily redeemable noncontrolling interest obligation, which the Company recorded as interest expense in the first quarter of 2025. The remaining mandatorily redeemable noncontrolling interest obligation related to GHC One and GHC Two LLC (GHC Two) was $7.3 million at September 30, 2026, with $6.0 million included in current liabilities due to the expected dissolution of GHC One within one year.
In December 2024, the Company acquired some of the minority-owned shares of CSI for a total estimated amount of $2.0 million. The Company paid cash of $0.6 million and entered into a promissory note with the minority owner for the remaining $1.4 million at an interest rate of 5.5% per annum. The note was included in other indebtedness (see Note 7) and was due and payable on January 31, 2026. Following the redemption, the Company owned 87.5% of CSI. Pursuant to the terms of the purchase agreement, the purchase price was finalized in December 2025, resulting in an additional amount payable of $0.1 million, plus interest at 5.5% per annum, to the minority owner. The note was subsequently paid in the first quarter of 2026.
As of September 30, 2026, the Company holds a controlling financial interest in GHC One and GHC Two and therefore includes the assets, liabilities, results of operations and cash flows in its consolidated financial statements. GHC One acquired Clarus during 2019. GHC Two acquired Impact Medical during 2021 and Skin Clique and Surpass in 2022. The Company accounts for the minority ownership of the group of current and former senior managers in GHC One and GHC Two as a mandatorily redeemable noncontrolling interest (see Note 8).
3. INVESTMENTS
Money Market Investments. As of September 30, 2026 and December 31, 2025, the Company had money market investments of $7.9 million and $5.3 million, respectively, that are classified as cash and cash equivalents in the Company’s Condensed Consolidated Balance Sheets.
Investments in Marketable Equity Securities. Investments in marketable equity securities consist of the following:
  As of
September 30,
2026
December 31,
2025
(in thousands)
Total cost
$255,193 $256,897 
Gross unrealized gains
817,174 845,889 
Gross unrealized losses(2,626)(20,848)
Total Fair Value
$1,069,741 $1,081,938 
At September 30, 2026 and December 31, 2025, the Company owned 63,793 and 55,430 shares, respectively, in Markel Group Inc. (Markel) valued at $109.2 million and $119.2 million, respectively. The Chief Executive Officer of Markel, Mr. Thomas S. Gayner, is a member of the Company’s Board of Directors. As of September 30, 2026, the Company owned 422 Class A and 481,920 Class B shares in Berkshire Hathaway valued at $555.2 million, which exceeded 5% of the Company’s total assets.
The Company purchased $25.0 million and $29.8 million of marketable equity securities during the first nine months of 2026 and 2025, respectively.
During the first nine months of 2026, the gross cumulative realized net gains from the sales of marketable equity securities were $28.0 million. The total proceeds from such sales were $54.6 million. The Company donated marketable equity securities in the first nine months of 2026 and 2025, and recorded $0.5 million and $0.4 million of gross cumulative realized gains from the donations, respectively. There were no sales of marketable equity securities during the first nine months of 2025.
11


The net gain (loss) on marketable equity securities comprised the following:

Three Months Ended 
 September 30

Nine Months Ended 
 September 30
(in thousands)
2026202520262025
(Loss) gain on marketable equity securities, net$(15,027)$84,768 $17,929 $117,026 
Less: Net losses (gains) in earnings from marketable equity securities sold and donated13,589 (25)11,178 (25)
Net unrealized (losses) gains in earnings from marketable equity securities still held at the end of the period$(1,438)

$84,743 

$29,107 $117,001 
Investments in Affiliates. As of September 30, 2026, the Company’s healthcare subsidiary held investments in several affiliates that GHG actively manages; GHG held a 40% interest in each of the following affiliates: Residential Home Health Illinois, Residential Hospice Illinois, Mary Free Bed at Home, and Allegheny Health Network Healthcare at Home. For the three and nine months ended September 30, 2026, the Company recorded $4.4 million and $12.8 million, respectively, in revenue for services provided to the affiliates of GHG. For the three and nine months ended September 30, 2025, the Company recorded $4.2 million and $12.1 million, respectively, in revenue for services provided to the affiliates of GHG.
As of September 30, 2026, the Company held a 50.6%, 41.5% and 25.6% interest in N2K Networks, Realm and Intersection, respectively, on a fully diluted basis, and accounts for these investments under the equity method. The Company holds two of the five seats of N2K Networks’ governing board with the other shareholders retaining substantive participation rights to control the financial and operating decisions of N2K Networks through representation on the board. In May 2024, the Company entered into a convertible promissory note agreement to loan N2K Networks $2.0 million. The convertible promissory note bears interest at a rate of 12% per annum and, subject to conversion provisions, all unpaid interest and principal are due on or after May 28, 2027.
In the third quarter of 2026, the Company recorded an impairment charge of $0.5 million on one of its investments in affiliates. In the second quarter of 2026, the Company recorded an impairment charge of $5.8 million on its investment in Realm following a reduction in the investee’s current and expected growth.
In September 2025, the Company invested an additional $29.3 million in Intersection. Intersection used a portion of the additional investment to settle, in a non-cash exchange, $19.3 million of the outstanding amount owed to the Company on the $30 million term loan extended in April 2023. Following the additional investment, the Company recognized a gain of $18.6 million in equity earnings.
The Company had $24.9 million and $30.0 million in its investment account that represents cumulative undistributed income in its investments in affiliates as of September 30, 2026 and December 31, 2025, respectively.
Additionally, Kaplan International Holdings Limited (KIHL) held a 45% interest in a joint venture formed with University of York. KIHL loaned the joint venture £22 million, which is repayable over 25 years at an interest rate of 7% and guaranteed by the University of York. The outstanding balance on this loan was £18.2 million as of September 30, 2026. The loan is repayable by December 2041.
Cost Method Investments. The Company held investments without readily determinable fair values in a number of equity securities that are accounted for as cost method investments, which are recorded at cost, less impairment, and adjusted for observable price changes for identical or similar investments of the same issuer. The carrying value of these investments was $49.3 million and $49.4 million as of September 30, 2026 and December 31, 2025, respectively. During the three and nine months ended September 30, 2026, the Company recorded impairment losses of $0.1 million to equity securities that are accounted for as cost method investments. During the three and nine months ended September 30, 2025, the Company recorded impairment losses of $1.5 million and $14.2 million, respectively, to equity securities that are accounted for as cost method investments.
4. ACCOUNTS RECEIVABLE, ACCOUNTS PAYABLE, VEHICLE FLOOR PLAN PAYABLE AND ACCRUED LIABILITIES
Accounts receivable consist of the following:
As of
September 30,
2026
December 31,
2025
(in thousands)
Receivables from contracts with customers, less estimated credit losses of $26,193 and $23,164
$492,180 $519,068 
Other receivables45,471 57,686 
$537,651 $576,754 
12


Credit loss expense was $1.7 million and $0.8 million for the three months ended September 30, 2026 and 2025, respectively. Credit loss expense was $4.7 million and $2.9 million for the nine months ended September 30, 2026 and 2025, respectively.
Accounts payable, vehicle floor plan payable and accrued liabilities consist of the following:
As of
September 30,
2026
December 31,
2025
(in thousands)
Accounts payable$176,357 $181,009 
Vehicle floor plan payable123,822 118,959 
Accrued compensation and related benefits161,462 194,972 
Other accrued liabilities229,833 226,686 
$691,474 $721,626 
Cash overdrafts of $2.6 million and $0.6 million are included in accounts payable as of September 30, 2026 and December 31, 2025.
The Company finances new, used and service loaner vehicle inventory through standardized floor plan facilities with Truist Bank and Toyota Motor Credit Corporation and Ford Motor Credit Company. At September 30, 2026, the floor plan facilities bore interest at variable rates that are based on Secured Overnight Financing Rate (SOFR) and prime-based interest rates. The weighted average interest rate for the floor plan facilities was 5.6% for the three and nine months ended September 30, 2026. The weighted average interest rate for the floor plan facilities was 6.2% and 6.3% for the three and nine months ended September 30, 2025, respectively. The Company incurred floor plan interest expense of $1.7 million for the three months ended September 30, 2026 and 2025. The Company incurred floor plan interest expense of $5.2 million and $5.8 million for the nine months ended September 30, 2026 and 2025, respectively. Changes in the vehicle floor plan payable are reported as cash flows from financing activities in the Condensed Consolidated Statements of Cash Flows.
The floor plan facilities are collateralized by vehicle inventory and other assets of the relevant dealership subsidiary, and contain a number of covenants, including, among others, covenants restricting the dealership subsidiary with respect to the creation of liens and changes in ownership, officers and key management personnel. The Company was in compliance with all of these restrictive covenants as of September 30, 2026.
The floor plan interest expense related to the vehicle floor plan arrangements is offset by amounts received from manufacturers in the form of floor plan assistance capitalized in inventory and recorded against cost of goods sold in the Condensed Consolidated Statements of Operations when the associated inventory is sold. For the three months ended September 30, 2026 and 2025, the Company recognized a reduction in cost of goods sold of $2.2 million and $2.1 million, respectively, related to manufacturer floor plan assistance. For the nine months ended September 30, 2026 and 2025, the Company recognized a reduction in cost of goods sold of $6.3 million and $6.1 million, respectively, related to manufacturer floor plan assistance.
As of September 30, 2026 and December 31, 2025, the Company had $109.3 million and $105.9 million, respectively, in obligations outstanding related to floor plan facilities associated with new vehicles.
5. INVENTORIES AND CONTRACTS IN PROGRESS
Inventories and contracts in progress consist of the following:
As of
September 30,
2026
December 31,
2025
(in thousands)
Raw materials$87,646 $77,977 
Work-in-process14,937 12,906 
Finished goods245,624 209,287 
Contracts in progress6,250 3,200 
$354,457 $303,370 
6. GOODWILL AND OTHER INTANGIBLE ASSETS
During the first quarter of 2026, in connection with the classification of the KLG disposal group as held for sale, the Company recognized a goodwill impairment charge of $1.0 million at Kaplan International (see Note 2).
Amortization of intangible assets for the three months ended September 30, 2026 and 2025, was $5.8 million and $9.7 million, respectively. Amortization of intangible assets for the nine months ended September 30, 2026 and
13


2025, was $17.8 million and $24.8 million, respectively. Amortization of intangible assets is estimated to be approximately $6 million for the remainder of 2026, $9 million in 2027, $6 million in 2028, $5 million in 2029, $5 million in 2030 and $13 million thereafter.
The changes in the carrying amount of goodwill, by segment, were as follows:
(in thousands)EducationTelevision
Broadcasting
HealthcareManufacturingAutomotiveOther
Businesses
Total
As of December 31, 2025        
Goodwill$1,181,284 $190,815 $136,637 $272,523 $140,832 $108,943 $2,031,034 
Accumulated impairment losses
(331,151)— — (82,062)— (32,155)(445,368)
850,133 190,815 136,637 190,461 140,832 76,788 1,585,666 
Acquisition— — 18,121 — — — 18,121 
Impairment(976)— — — — — (976)
Disposition— — — — — — — 
Reclassification to assets held for sale(51,786)— — — — — (51,786)
Foreign currency exchange rate changes
368 — — — — — 368 
As of September 30, 2026        
Goodwill1,128,890 190,815 154,758 272,523 140,832 108,943 1,996,761 
Accumulated impairment losses
(331,151)— — (82,062)— (32,155)(445,368)
$797,739 $190,815 $154,758 $190,461 $140,832 $76,788 $1,551,393 
The changes in carrying amount of goodwill at the Company’s education and healthcare divisions were as follows:
(in thousands)
Kaplan
International
Higher
Education
Supplemental EducationTotal
Education
CSIOther HealthcareTotal Healthcare
As of December 31, 2025      
Goodwill$614,096 $174,564 $392,624 $1,181,284 $87,140 $49,497 $136,637 
Accumulated impairment losses— (111,324)(219,827)(331,151)— — — 
614,096 63,240 172,797 850,133 87,140 49,497 136,637 
Acquisition— — — — — 18,121 18,121 
Impairment(976)— — (976)— — — 
Disposition— — — — — — — 
Reclassification to assets held for sale(51,786)— — (51,786)— — — 
Foreign currency exchange rate changes431 — (63)368 — — — 
As of September 30, 2026      
Goodwill561,765 174,564 392,561 1,128,890 87,140 67,618 154,758 
Accumulated impairment losses— (111,324)(219,827)(331,151)— — — 
$561,765 $63,240 $172,734 $797,739 $87,140 $67,618 $154,758 
14


Other intangible assets consist of the following:
As of September 30, 2026As of December 31, 2025
(in thousands)Useful Life
Range
Gross
Carrying
Amount
Accumulated
Amortization
Net Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
 Carrying
Amount
Amortized Intangible Assets              
Student and customer relationships
2–10 years
$286,235 $257,124 $29,111 $307,312 $266,453 $40,859 
Trade names and trademarks
2–10 years
107,338 95,613 11,725 114,227 98,147 16,080 
Network affiliation agreements
10 years
17,400 16,893 507 17,400 15,588 1,812 
Databases and technology
3–6 years
30,496 28,811 1,685 32,376 30,293 2,083 
Other
1–8 years
37,863 37,256 607 38,063 37,266 797 
    $479,332 $435,697 $43,635 $509,378 $447,747 $61,631 
Indefinite-Lived Intangible Assets
              
Franchise agreements$97,002 $97,002 
Trade names and trademarks  62,187     62,653     
FCC licenses11,000 11,000 
Other150 150 
  $170,339 $170,805 
7. DEBT
The Company’s borrowings consist of the following:
  As of
(in thousands)MaturitiesStated Interest RateEffective Interest RateSeptember 30,
2026
December 31,
2025
Unsecured notes (1)
20335.625%5.625%$493,971 $493,625 
Revolving credit facility2030
5.00% - 7.13%
5.12%186,165 222,466 
Real estate term loan (2)
2028
5.37% - 5.46%
5.48%88,116 91,836 
Capital term loan (3)
2028
6.12% - 6.21%
6.22%58,302 64,079 
Other indebtedness2028 - 2030
5.50% - 8.00%
26,880 8,750 
Total Debt853,434 880,756 
Less: current portion(148,075)(175,138)
Total Long-Term Debt$705,359 $705,618 
___________
(1)     The carrying value is net of $6.0 million and $6.4 million of unamortized debt issuance costs as of September 30, 2026 and December 31, 2025, respectively.
(2)     The carrying value is net of $0.1 million of unamortized debt issuance costs as of September 30, 2026 and December 31, 2025.
(3)     The carrying value is net of $0.3 million and $0.5 million of unamortized debt issuance costs as of September 30, 2026 and December 31, 2025, respectively.
On November 24, 2025, the Company issued $500 million of 5.625% unsecured eight-year fixed-rate notes due December 1, 2033 (the Notes). Interest is paid semi-annually on June 1 and December 1. Also on November 24, 2025, the Company used the net proceeds from the sale of the Notes, together with the borrowings under the revolving credit agreement, to (i) redeem the $400 million of 5.75% unsecured notes due June 1, 2026, (ii) refinance outstanding revolving loans under the existing revolving credit facility, and (iii) repay all amounts outstanding under the Company’s existing $150 million term loan. On October 21, 2025, the automotive subsidiary borrowed $38.7 million under the delayed draw term loan to finance the acquisition of a Honda automotive dealership, including the real property for the dealership operations.
In combination with the issuance of the Notes, the Company amended and restated the Second Amended and Restated Five Year Credit Agreement, dated as of May 3, 2022, to, among other things, (i) increase the Company’s borrowing capacity by replacing the existing revolving commitments with a new revolving credit facility in the aggregate principal amount of $400 million, (ii) extend the maturity of the facility to November 24, 2030, and (iii) increase the letter of credit sublimit to $40 million.
At September 30, 2026 and December 31, 2025, the fair value of the Company’s 5.625% unsecured notes, based on quoted market prices (Level 2 fair value assessment), totaled $470.3 million and $504.0 million, respectively.
The outstanding balance on the Company’s $400 million unsecured revolving credit facility was $186.2 million as of September 30, 2026, consisting of U.S. dollar borrowings of $120.0 million with interest payable at SOFR plus
15


1.375%, and British Pound borrowings of £50 million with interest payable at Daily Sterling Overnight Index Average (SONIA) plus 1.375%.
The fair value of the Company’s other debt, which is based on Level 2 inputs, approximates its carrying value as of September 30, 2026 and December 31, 2025. The Company is in compliance with all financial covenants of the revolving credit facility and term loans as of September 30, 2026.
During the three months ended September 30, 2026 and 2025, the Company had average borrowings outstanding of approximately $930.4 million and $856.8 million, respectively, at average annual interest rates of approximately 5.9% and 6.0%, respectively. During the three months ended September 30, 2026 and 2025, the Company incurred net interest expense of $14.2 million and $15.7 million, respectively.
During the nine months ended September 30, 2026 and 2025, the Company had average borrowings outstanding of approximately $906.7 million and $835.2 million, respectively, at average annual interest rates of approximately 5.8% and 6.0%, respectively. During the nine months ended September 30, 2026 and 2025, the Company incurred net interest expense of $43.2 million and $111.3 million, respectively.
During the three and nine months ended September 30, 2026, the Company recorded a reduction in interest expense of $0.1 million and $1.0 million, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest. During the three and nine months ended September 30, 2025, the Company recorded interest expense of $0.7 million and $68.3 million, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest. The fair value of the mandatorily redeemable noncontrolling interest was based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined by reference to either a discounted cash flow or EBITDA multiple, which approximates fair value (Level 3 fair value assessment) (See Note 2 and 8).
16


8. FAIR VALUE MEASUREMENTS
The Company’s financial assets and liabilities measured at fair value on a recurring basis were as follows:
As of September 30, 2026
(in thousands)Level 1Level 2Level 3Total
Assets      
Money market investments (1) 
$— $7,913 $— $7,913 
Marketable equity securities (2)
1,069,741 — — 1,069,741 
Other current investments (3)
— 4,330 — 4,330 
Total Financial Assets
$1,069,741 $12,243 $— $1,081,984 
Liabilities
  
  
  
Interest rate swaps (4) 
$— $60 $— $60 
Mandatorily redeemable noncontrolling interest (5)
— — 7,273 7,273 
Total Financial Liabilities
$— $60 $7,273 $7,333 

As of December 31, 2025
(in thousands)Level 1Level 2Level 3Total
Assets
  
  

  
Money market investments (1) 
$— $5,251 $— $5,251 
Marketable equity securities (2)
1,081,938 — — 1,081,938 
Other current investments (3)
— 7,032 — 7,032 
Total Financial Assets
$1,081,938 $12,283 $— $1,094,221 
Liabilities
  
  

  
Contingent consideration liabilities (6)
$— $— $1,526 $1,526 
Interest rate swaps (4)
— 2,289 — 2,289 
Mandatorily redeemable noncontrolling interest (5)
— — 8,401 8,401 
Total Financial Liabilities
$— $2,289 $9,927 $12,216 
____________
(1)
The Company’s money market investments are included in cash and cash equivalents and the value considers the liquidity of the counterparty.
(2)
The Company’s investments in marketable equity securities are held in common shares of U.S. and non-U.S. corporations that are actively traded on U.S. and non-U.S. stock exchanges. Price quotes for these shares are readily available.
(3)
Includes mutual funds, which are valued using a market approach based on the quoted market prices of the security or inputs that include quoted market prices for similar instruments.
(4)
Included in Other Liabilities. The Company utilized a market approach model using the notional amount of the interest rate swaps multiplied by the observable inputs of time to maturity and market interest rates.
(5)
The fair value of the mandatorily redeemable noncontrolling interest is based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined using enterprise value analyses which include an equal weighing between guideline public company and discounted cash flow analyses.
(6)
Included in Accounts payable, vehicle floor plan payable and accrued liabilities and Other Liabilities. The Company determined the fair value of the contingent consideration liabilities using either a Monte Carlo simulation, Black-Scholes model, or probability-weighted analysis depending on the type of target included in the contingent consideration requirements (revenue, EBITDA, client retention). All analyses included estimated financial projections for the acquired businesses and acquisition-specific discount rates.

17


The following tables provide a reconciliation of changes in the Company’s financial liabilities measured at fair value on a recurring basis, using Level 3 inputs:
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2025
$1,526 $8,401 
Changes in fair value (1)
— (1,007)
Capital contributions
— 4 
Accretion of value included in net income (1)
28 — 
Settlements or distributions
(299)(125)
Foreign currency exchange rate changes
(2)— 
Disposition of business(1,253)— 
As of September 30, 2026
$— $7,273 
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2024$1,419 $159,548 
Changes in fair value (1)
— 68,278 
Capital contributions
— 80 
Accretion of value included in net income (1)
163 — 
Settlements or distributions
(317)(205,719)
Foreign currency exchange rate changes
186 — 
As of September 30, 2025$1,451 $22,187 
____________
(1)Changes in fair value and accretion of value of contingent consideration liabilities are included in Selling, general and administrative expenses and the changes in fair value of mandatorily redeemable noncontrolling interest is included in Interest expense in the Company’s Condensed Consolidated Statements of Operations.
Mandatorily Redeemable Noncontrolling Interest. The mandatorily redeemable noncontrolling interest represents the ownership portion of a group of minority shareholders, consisting of a group of current and former senior managers of the healthcare business, in subsidiaries of GHG. The Company established GHC One and GHC Two as vehicles to invest in a portfolio of healthcare businesses together with the group of senior managers of GHG. As the holder of preferred units, the Company is obligated to contribute 95% of the capital required for the acquisition of portfolio investments with the remaining 5% of the capital coming from the group of senior managers. The operating agreements of GHC One and GHC Two require the dissolution of the entities on March 31, 2026, and March 31, 2029, respectively, at which time the net assets will be distributed to its members. As a preferred unit holder, the Company will receive an amount up to its contributed capital plus a preferred annual return of 8% (guaranteed return) after the group of senior managers has received the redemption of their 5% interest in net assets (manager return). All distributions in excess of the manager and guaranteed return will be paid to common unit holders, which currently comprise the group of senior managers of GHG. The Company may convert its preferred units to common units at any time after which it will receive 80% of all distributions in excess of the manager return, with the remaining 20% of excess distributions going to the group of senior managers as holders of the other common units. The mandatorily redeemable noncontrolling interest related to GHC One is reported as a current liability at September 30, 2026 and December 31, 2025 in the Condensed Consolidated Balance Sheets. The mandatorily redeemable noncontrolling interest related to GHC Two is reported as a noncurrent liability at September 30, 2026 and December 31, 2025 in the Condensed Consolidated Balance Sheets.
Other. During the nine months ended September 30, 2026, in connection with the sale of the KLG disposal group, the Company recognized total impairment charges of $19.0 million, consisting of a $1.0 million goodwill impairment charge and an $18.0 million impairment charge related to the disposal group. The Company used a market approach to estimate the fair value of KLG disposal group (see Note 2 and 6).
During the three and nine months ended September 30, 2025, the Company recorded intangible and other long-lived asset impairment charges of $2.2 million. The remeasurement of other long-lived assets is classified as a Level 3 fair value assessment due to the significance of unobservable inputs developed in the determination of the fair value. The Company used a discounted cash flow model to determine the estimated fair value of the other long-lived assets. The Company made estimates and assumptions regarding future cash flows, discount rates and long-term growth rates.
During the three and nine months ended September 30, 2026, the Company recorded impairment charges of $0.5 million and $6.3 million on its investments in affiliates (see Note 3). The Company used a market approach to determine the estimated fair value of its investment in affiliates.
18


During the three and nine months ended September 30, 2026, the Company recorded impairment losses of $0.1 million, to equity securities that are accounted for as cost method investments. During the three and nine months ended September 30, 2025, the Company recorded impairment losses of $1.5 million and $14.2 million, respectively, to equity securities that are accounted for as cost method investments.
9. INCOME TAXES
The Company recognized a U.S. income tax benefit of $68.1 million for the nine months ended September 30, 2026, in connection with the restructuring and sale of the KLG business. No corresponding tax benefit was recognized in any other jurisdiction. The Company continues to monitor relevant developments, including any forthcoming Internal Revenue Service guidance, that could affect the ultimate realization of this benefit.
As a result of the significant U.S. income tax benefit recorded related to the KLG business, the Company has recorded a Pillar Two top-up income tax accrual and expense of $15.3 million for the nine months ended September 30, 2026. In January 2026, the Organization for Economic Co-operation and Development (OECD) published administrative guidance introducing a Side-by-Side (SbS) Safe Harbor that would effectively exempt U.S. parent multinational groups from Pillar Two top-up tax on their U.S. source income. The SbS Safe Harbor is only effective to the extent participating countries have enacted legislation adopting the guidance. The Company has assessed current law and administrative guidance in relevant non-U.S. jurisdictions. Currently, not all participating countries have enacted legislation to adopt the SbS Safe Harbor, including the U.K. The Company will continue to monitor local implementation and guidance as non-U.S. countries adopt the SbS Safe Harbor into domestic law. The enactment of such legislation in the U.K. and other jurisdictions would have a favorable impact on the Pillar Two top-up tax accrued for 2026, and could result in a complete reversal of the $15.3 million accrued amount without payment.
The Company's effective tax rate for the first nine months of 2026 and 2025 was 14.6% and 30.6%, respectively.
10. REVENUE FROM CONTRACTS WITH CUSTOMERS
The Company generated 83% and 81% of its revenue from U.S. domestic sales for the three and nine months ended September 30, 2026, respectively. The remaining 17% and 19% of revenue was generated from non-U.S. sales for the three and nine months ended September 30, 2026, respectively. For the three and nine months ended September 30, 2025, 79% and 78% of revenue, respectively, was from U.S. domestic sales and the remaining 21% and 22% of revenue was generated from non-U.S. sales.
For the three and nine months ended September 30, 2026, the Company recognized 47% and 51%, respectively, of its revenue over time as control of the services and goods transferred to the customer, and the remaining 53% and 49% at a point in time, when the customer obtained control of the promised goods. For the three and nine months ended September 30, 2025, the Company recognized 51% and 53% of its revenue, respectively, over time, and the remaining 49% and 47% at a point in time.
Contract Assets. As of September 30, 2026, the Company recognized a contract asset of $29.0 million related to a contract at a Kaplan International business, of which $5.8 million is included in Other current assets and $23.2 million is included in Deferred Charges and Other Assets. The Company expects to recognize an additional $186.7 million related to the remaining performance obligation in the contract over the next three years. As of December 31, 2025, the contract asset was $36.5 million, of which $4.4 million was included in Other current assets and $32.1 million was included in Deferred Charges and Other Assets. Additional contract assets of $4.0 million and $3.0 million are included in Other current assets on the Company’s Condensed Consolidated Balance Sheets as of September 30, 2026 and December 31, 2025, respectively.
Deferred Revenue. The Company records deferred revenue when cash payments are received or due in advance of the Company’s performance which includes some payments that are refundable due to the contractual right of the customer to cancel the agreement. As of September 30, 2026 and December 31, 2025, 17% and 22%, respectively, of the Company’s deferred revenue consisted of prepaid amounts which are refundable. The following table presents the change in the Company’s deferred revenue balance:
As of
September 30,
2026
December 31,
2025
%
(in thousands)Change
Deferred revenue$359,038 $418,090 (14)
The majority of the change in the deferred revenue balance is related to the cyclical nature of services in the Kaplan International division, the reclassification of deferred revenue included in the DBS disposal group and the derecognition of deferred revenue associated with the sale of the KLG businesses in May 2026 (see Note 2). During the nine months ended September 30, 2026, the Company recognized $348.7 million related to the Company’s
19


deferred revenue balance as of December 31, 2025, including $67.1 million of prepaid amounts which were refundable at the prior year-end.
Revenue allocated to remaining performance obligations represents deferred revenue amounts that will be recognized as revenue in future periods. As of September 30, 2026, the deferred revenue balance related to certain medical and nursing qualifications with an original contract length greater than twelve months at Kaplan Supplemental Education was $4.3 million. Kaplan Supplemental Education expects to recognize 57% of this revenue over the next twelve months and the remainder thereafter.
Costs to Obtain a Contract. The following table presents changes in the Company’s costs to obtain a contract asset:
(in thousands)Balance at
Beginning
of Period
Costs associated with new contractsLess: Costs amortized during the periodOtherBalance
at
End of
Period
2026$42,404 $57,187 $(67,312)$(4,852)$27,427 
The majority of other activity was related to the reclassification of costs to obtain contract assets included in the DBS disposal group, the derecognition of costs to obtain contract assets associated with the sale of the KLG business in May 2026 (see Note 2) and currency translation adjustments for the nine months ended September 30, 2026.
11. EARNINGS PER SHARE
The Company’s unvested restricted stock awards contain nonforfeitable rights to dividends and, therefore, are considered participating securities for purposes of computing earnings per share pursuant to the two-class method. The diluted earnings per share computed under the two-class method is lower than the diluted earnings per share computed under the treasury stock method, resulting in the presentation of the lower amount in diluted earnings per share. The computation of the earnings per share under the two-class method excludes the income attributable to the unvested restricted stock awards from the numerator and excludes the dilutive impact of those underlying shares from the denominator.
20


The following reflects the Company’s net income and share data used in the basic and diluted earnings per share computations using the two-class method:
Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands, except per share amounts)2026202520262025
Numerator:
Numerator for basic earnings per share:
        
Net income attributable to Graham Holdings Company common stockholders
$75,110 $122,925 $385,319 $183,568 
Less: Dividends paid-common stock outstanding and unvested restricted shares
(7,803)(7,852)(32,154)(31,360)
Undistributed earnings
67,307 115,073 353,165 152,208 
Percent allocated to common stockholders99.43 %99.39 %99.43 %99.39 %
66,921 114,372 351,139 151,280 
Add: Dividends paid-common stock outstanding7,758 7,803 31,974 31,168 
Numerator for basic earnings per share
$74,679 $122,175 $383,113 $182,448 
Add: Additional undistributed earnings due to dilutive stock options
4 7 21 8 
Numerator for diluted earnings per share
$74,683 $122,182 $383,134 $182,456 
Denominator:    
Denominator for basic earnings per share:
Weighted average shares outstanding4,198 4,334 4,264 4,329 
Add: Effect of dilutive stock options45 44 45 41 
Denominator for diluted earnings per share
4,243 4,378 4,309 4,370 
Graham Holdings Company Common Stockholders:        
Basic earnings per share
$17.79 $28.19 $89.84 $42.15 
Diluted earnings per share
$17.60 $27.91 $88.92 $41.75 
____________
Earnings per share amounts may not recalculate due to rounding.
Diluted earnings per share excludes the following weighted average potential common shares, as the effect would be antidilutive, as computed under the treasury stock method:
Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands)2026202520262025
Weighted average restricted stock19 16 18 14 
The diluted earnings per share amounts for each of the three and nine months ended September 30, 2026 and 2025 excludes the effect of 1,000 contingently issuable shares outstanding as their inclusion would have been antidilutive due to a market condition.
In the three and nine months ended September 30, 2026, the Company declared regular dividends totaling $1.88 and $7.52 per common share, respectively. In the three and nine months ended September 30, 2025, the Company declared regular dividends totaling $1.80 and $7.20 per common share, respectively.
21


12. PENSION PLANS
Defined Benefit Plans. The total benefit arising from the Company’s defined benefit pension plans consists of the following components:
  Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands)2026202520262025
Service cost$12,379 $11,772 $35,881 $35,663 
Interest cost8,145 8,012 24,437 21,389 
Expected return on assets(44,409)(41,915)(133,227)(125,767)
Amortization of prior service credit(496)(520)(1,489)(1,560)
Net Periodic Benefit(24,381)(22,651)(74,398)(70,275)
Settlement(14,950)— (151,905)— 
Early retirement and separation program costs3,201 2,546 11,138 9,185 
Total Benefit$(36,130)$(20,105)$(215,165)$(61,090)
In June 2026, the Company purchased an irrevocable group annuity contract from an insurance company for $113.9 million to settle $124.3 million of the outstanding defined benefit pension obligation related to certain retirees and beneficiaries. The purchase of the group annuity contract was funded from the assets of the Company’s pension plan. As a result of this transaction, the Company was relieved of all responsibility for these pension obligations and the insurance company is now required to pay and administer the retirement benefits owed to approximately 1,080 retirees and beneficiaries, with no change to the amount, timing or form of monthly retirement benefit payments. As a result, the Company remeasured the accumulated and projected benefit obligation as of June 17, 2026 and recorded a pre-tax settlement gain of $137.0 million. In the third quarter of 2026, the Company made additional lump-sum payments that triggered a remeasurement of its accumulated and projected benefit obligations as of September 30, 2026, resulting in a pre-tax settlement gain of $15.0 million. The new measurement bases were used for the recognition of the Company’s pension benefit following the remeasurements. The settlement gains are included in non-operating pension and postretirement benefit income on the Condensed Consolidated Statements of Operations.
In the third quarter of 2026, the Company recorded $2.4 million in expenses related to a Separation Incentive Program (SIP) for certain Kaplan, Dekko, Framebridge and Saatchi Art employees. Also in the third quarter of 2026, the Company recorded $0.8 million in expenses related to a Voluntary Retirement Incentive Program (VRIP) for certain Corporate employees. In the second quarter of 2026, the Company recorded $2.0 million in expenses related to a VRIP for certain Dekko employees. Also in the second quarter of 2026, the Company recorded $1.9 million in expenses related to SIPs for certain Kaplan, Graham Media Group (GMG), Code3 and Slate employees. In the first quarter of 2026, the Company recorded $4.1 million in expenses related to SIPs for certain Kaplan, GMG, Joyce, Dekko, Framebridge, Code3, Slate and Corporate employees. These SIPs and VRIPs were funded from the assets of the Company’s pension plans.
In the third quarter of 2025, the Company recorded $2.5 million in expenses related to SIPs for certain Kaplan, GMG, Joyce, Society6, Saatchi Art, Code3 and Corporate employees. In the second quarter of 2025, the Company recorded $6.0 million in expenses related to SIPs for certain Kaplan, GMG, WGB, Saatchi Art, Society6, Code3 and Decile employees. In the first quarter of 2025, the Company recorded $0.6 million in expenses related to a SIP for certain WGB employees. These SIPs were funded from the assets of the Company’s pension plans.
The total cost arising from the Company’s Supplemental Executive Retirement Plan (SERP) consists of the following components:
  Three Months Ended 
 September 30
Nine Months Ended 
 September 30
(in thousands)2026202520262025
Service cost$289 $239 $868 $716 
Interest cost1,154 1,198 3,464 3,592 
Net Periodic Cost$1,443 $1,437 $4,332 $4,308 
22


Defined Benefit Plan Assets. The Company’s defined benefit pension obligations are funded by a portfolio made up of private investment funds and a relatively small number of stocks and high-quality fixed-income securities that are held by a third-party trustee. The assets of the Company’s pension plans were allocated as follows:
  As of
  September 30,
2026
December 31,
2025
  
U.S. equities62 %63 %
Private investment funds18 %17 %
International equities17 %16 %
U.S. fixed income3 %4 %
  100 %100 %
The Company manages approximately 41% of the pension assets internally, of which the majority is invested in Berkshire Hathaway stock, with the remaining investments in private investment funds, Markel stock, and short-term fixed-income securities. The remaining 59% of plan assets are managed by two investment companies. The goal of the investment managers is to produce moderate long-term growth in the value of these assets, while protecting them against large decreases in value. Both investment managers may invest in a combination of equity and fixed-income securities and cash. The managers are not permitted to invest in securities of the Company or in alternative investments. One investment manager cannot invest more than 15% of the assets at the time of purchase in each of the stocks of Alphabet and Berkshire Hathaway, and no more than 50% of the assets it manages in specified international exchanges at the time the investment is made. The other investment manager cannot invest more than 20% of the assets at the time of purchase in the stock of Berkshire Hathaway and no more than 15% of the assets it manages in specified international exchanges at the time the investment is made. Excluding the exceptions noted above, the investment managers cannot invest more than 10% of the assets in the securities of any other single issuer, except for obligations of the U.S. Government, without receiving prior approval from the Plan administrator.
In determining the expected rate of return on plan assets, the Company considers the relative weighting of plan assets, the historical performance of total plan assets and individual asset classes and economic and other indicators of future performance. In addition, the Company may consult with and consider the input of financial and other professionals in developing appropriate return benchmarks.
The Company evaluated its defined benefit pension plan asset portfolio for the existence of significant concentrations (defined as greater than 10% of plan assets) of credit risk as of September 30, 2026. Types of concentrations that were evaluated include, but are not limited to, investment concentrations in a single entity, type of industry, foreign country and individual fund. At September 30, 2026, the pension plan held investments in one common stock and one private investment fund that exceeded 10% of total plan assets, valued at $1,253.7 million, or approximately 38% of total plan assets. At December 31, 2025, the pension plan held investments in one common stock and one private investment fund that exceeded 10% of total plan assets, valued at $1,267.4 million, or approximately 37% of total plan assets. Assets also included $99.3 million and $124.7 million of Markel shares at September 30, 2026 and December 31, 2025, respectively.
13. OTHER NON-OPERATING (EXPENSE) INCOME
A summary of non-operating (expense) income is as follows:

Three Months Ended 
 September 30

Nine Months Ended 
 September 30
(in thousands)2026202520262025
(Loss) gain on sales of businesses$— $— $(5,151)$371 
Foreign currency (loss) gain, net(1,473)1,147 (2,034)(7,707)
Gain on sale of a cost method investment— — 484 — 
Impairment of cost method investments(100)(1,486)(100)(14,165)
Other gain, net386 346 2,655 987 
Total Other Non-Operating (Expense) Income$(1,187)$7 $(4,146)$(20,514)
In the second quarter of 2026, the Company recorded a $5.2 million loss related to Kaplan’s sale of KLG (see Note 2).
23


14. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The other comprehensive income (loss) consists of the following components:
Three Months Ended September 30
  20262025
  Before-TaxIncomeAfter-TaxBefore-TaxIncomeAfter-Tax
(in thousands)AmountTaxAmountAmountTaxAmount
Foreign currency translation adjustments:            
Translation adjustments arising during the period$3,309 $— $3,309 $(8,227)$— $(8,227)
Pension and other postretirement plans:            
Actuarial gain45,115 (11,736)33,379 — — — 
Amortization of net prior service credit included in net income(496)129 (367)(520)133 (387)
Amortization of net actuarial gain included in net income
(258)67 (191)(378)96 (282)
Settlement gain included in net income(14,950)3,889 (11,061)— — — 
29,411 (7,651)21,760 (898)229 (669)
Cash flow hedges:            
Gain for the period970 (251)719 64 (17)47 
Other Comprehensive Income (Loss)$33,690 $(7,902)$25,788 $(9,061)$212 $(8,849)
  Nine Months Ended September 30
  20262025
  Before-TaxIncomeAfter-TaxBefore-TaxIncomeAfter-Tax
(in thousands)AmountTaxAmountAmountTaxAmount
Foreign currency translation adjustments:            
Translation adjustments arising during the period$(2,814)$— $(2,814)$38,323 $— $38,323 
Adjustment for sales of businesses with foreign operations6,175 — 6,175 646 — 646 
3,361 — 3,361 38,969 — 38,969 
Pension and other postretirement plans:            
Actuarial loss(44,813)11,657 (33,156)— — — 
Amortization of net prior service credit included in net income(1,489)388 (1,101)(1,560)399 (1,161)
Amortization of net actuarial gain included in net income
(774)201 (573)(1,137)291 (846)
Settlement gain included in net income(151,905)39,514 (112,391)— — — 
  (198,981)51,760 (147,221)(2,697)690 (2,007)
Cash flow hedges:          
Gain (loss) for the period2,236 (579)1,657 (979)254 (725)
Other Comprehensive (Loss) Income$(193,384)$51,181 $(142,203)$35,293 $944 $36,237 
The accumulated balances related to each component of other comprehensive income (loss) are as follows:
(in thousands, net of taxes)Cumulative
Foreign
Currency
Translation
Adjustment
Unrealized Gain
on Pensions
and Other
Postretirement
Plans
Cash Flow
Hedges
Accumulated
Other
Comprehensive
Income
As of December 31, 2025$(12,262)$601,064 $(1,722)$587,080 
Other comprehensive (loss) income before reclassifications(2,814)(33,156)1,159 (34,811)
Net amount reclassified from accumulated other comprehensive income (loss)
6,175 (114,065)498 (107,392)
Net other comprehensive (loss) income3,361 (147,221)1,657 (142,203)
As of September 30, 2026$(8,901)$453,843 $(65)$444,877 
24


The amounts and line items of reclassifications out of Accumulated Other Comprehensive Income (Loss) are as follows:
  Three Months Ended 
 September 30
Nine Months Ended 
 September 30
Affected Line Item in the Condensed Consolidated Statements of Operations
  
(in thousands)2026202520262025
Foreign Currency Translation Adjustments:          
Adjustment for sales of businesses with foreign operations$— $— $6,175 $646 Other (expense) income, net
Pension and Other Postretirement Plans:        
Amortization of net prior service credit(496)(520)(1,489)(1,560)(1)
Amortization of net actuarial gain(258)(378)(774)(1,137)(1)
Settlement gain(14,950)— (151,905)— (1)
  (15,704)(898)(154,168)(2,697)Before tax
  4,085 229 40,103 690 Provision for Income Taxes
  (11,619)(669)(114,065)(2,007)Net of Tax
Cash Flow Hedges164 61 498 182 Interest expense
Total reclassification for the period$(11,455)$(608)$(107,392)$(1,179)Net of Tax
____________
(1)    These accumulated other comprehensive income (loss) components are included in the computation of net periodic pension and postretirement plan cost (see Note 12) and are included in non-operating pension and postretirement benefit income in the Company’s Condensed Consolidated Statements of Operations.
15. CONTINGENCIES
Litigation, Legal and Other Matters.  The Company and its subsidiaries are subject to complaints and administrative proceedings and are defendants in various civil lawsuits that have arisen in the ordinary course of their businesses, including contract disputes; actions alleging negligence, libel, defamation and invasion of privacy; trademark, copyright and patent infringement; real estate lease and sublease disputes; violations of employment laws and applicable wage and hour laws; and statutory or common law claims involving current and former students and employees. Although the outcomes of the legal claims and proceedings against the Company cannot be predicted with certainty, based on currently available information, management believes that there are no existing claims or proceedings that are likely to have a material effect on the Company’s business, financial condition, results of operations or cash flows. However, based on currently available information, management believes it is reasonably possible that future losses from existing and threatened legal, regulatory and other proceedings in excess of the amounts recorded could reach approximately $20 million.
16. BUSINESS SEGMENTS
The Company has seven reportable segments: Kaplan International, Kaplan Higher Education, Kaplan Supplemental Education, Television Broadcasting, CSI, Manufacturing and Automotive.
As of September 30, 2026, Kaplan had a total outstanding accounts receivable balance of $40.3 million from Purdue Global related to amounts due for reimbursements for services. As of September 30, 2026, the $20.0 million advanced during the initial KU Transaction has been fully repaid.

25


The Company’s segment information is as follows:
Three Months Ended September 30, 2026
(in thousands)EducationTelevision BroadcastingHealthcareManufacturingAutomotiveTotal Segments
Operating Revenues$404,282 $125,304 $260,252 $147,601 $299,060 $1,236,499 
Reconciliation of Revenue
Other Businesses and Corporate Office Revenues (1)
90,326 
Intersegment Elimination(788)
Total Consolidated Revenues$1,326,037 
Less: Significant Expenses (2)
Cost of Revenue (3)
171,537 175,082 109,015 252,299 707,933 
Payroll and Fringe Benefits Expense (4)
107,859 25,983 20,076 153,918 
Occupancy Expense22,990 2,041 25,031 
Advertising and Marketing Expense18,263 18,263 
Networking and Programming Expense28,137 28,137 
Management Services (5)
2,323 2,323 
Other Segment Items (6)
34,182 17,540 57,538 21,774 10,951 141,985 
Earnings Before Interest, Income Taxes, Depreciation, Amortization and Pension Service Cost (EBITDAP)$49,451 $53,644 $27,632 $16,812 $11,370 $158,909 
Pension Service Cost4,555 1,554 2,365 1,242 34 9,750 
Depreciation Expense5,524 2,271 1,952 2,855 1,993 14,595 
Income from Operations before Amortization of Intangible Assets$39,372 $49,819 $23,315 $12,715 $9,343 $134,564 
Other Businesses (7)
(21,352)
Corporate Costs(21,916)
Amortization of Intangible Assets(5,775)
Income from Operations$85,521 
Equity in Losses of Affiliates, Net(3,590)
Interest Expense, Net(14,175)
Non-Operating Pension and Postretirement Benefit Income, Net47,601 
Loss on Marketable Equity Securities, Net(15,027)
Other Expense, Net(1,187)
Income Before Income Taxes$99,143 
Capital Expenditures$5,977 $1,214 $14,534 $3,489 $3,674 $28,888 
Reconciliation of Capital Expenditures
Other Businesses and Corporate Office Capital Expenditures (8)
10,674 
Total Capital Expenditures$39,562 
(1)Revenue from segments below the quantitative thresholds is attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
(2)The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker (CODM).
(3)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(4)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(5)Management and operating services provided by Christopher J. Ourisman and his team of industry professionals.
(6)Other segment items for each reportable segment include:
(a)Education (includes Kaplan International, Kaplan Higher Education and Kaplan Supplemental Education) - training and employment expense, travel meals and entertainment expense, operating fees and other general and administrative (G&A) expenses.
(b)Television Broadcasting - other broadcast expenses, facilities expenses, third-party commission costs and other selling, general and administrative (SG&A) expenses.
(c)Healthcare - indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
(d)Manufacturing - payroll and fringe benefits expense (SG&A) and other SG&A expenses.
(e)Automotive - advertising and marketing expense and other G&A expenses.
(7)Profit or loss from operating segments below the quantitative thresholds attributable to Other Businesses as described above. These operating segments did not meet any of the quantitative thresholds for determining reportable segments.
(8)Capital Expenditures from operating segments below the quantitative thresholds are attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
26


The Company’s education division segment information is as follows:
Three Months Ended September 30, 2026
(in thousands)Kaplan InternationalHigher EducationSupplemental EducationKaplan Corporate and OtherIntersegment EliminationTotal Education
Operating Revenues$230,134 $93,865 $80,805 $369 $(891)$404,282 
Less: Significant Expenses (1)
Cost of Revenue (2)
90,588 67,770 13,537 (358)171,537 
Payroll and Fringe Benefits Expense (3)
67,592 3,851 33,455 3,174 (213)107,859 
Occupancy Expense21,905 169 823 368 (275)22,990 
Advertising and Marketing Expense7,366 1,547 9,313 37 18,263 
Other Segment Items (4)
21,025 262 11,236 1,617 42 34,182 
EBITDAP
$21,658 $20,266 $12,441 $(4,827)$(87)$49,451 
Pension Service Cost— 1,984 2,017 554 4,555 
Depreciation Expense4,366 378 769 11 5,524 
Income (Loss) from Operations before Amortization of Intangible Assets$17,292 $17,904 $9,655 $(5,392)$(87)$39,372 
Capital Expenditures$4,941 $289 $733 $14 $5,977 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(3)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(4)Other segment items for each reportable segment include:
(a)Kaplan international - travel meals and entertainment expense, training and employment expense, operating fees and other G&A expenses.
(b)Higher education - training and employment expense, operating fees and other G&A expenses.
(c)Supplemental education - training and employment expense, operating fees and other G&A expenses.
The Company’s healthcare division segment information is as follows:
Three Months Ended September 30, 2026
(in thousands)CSIOther HealthcareTotal Healthcare
Operating Revenues$162,289 $97,963 $260,252 
Less: Significant Expenses (1)
Cost of Revenue (2)
124,564 50,518 175,082 
Other Segment Items (3)
22,068 35,470 57,538 
EBITDAP
$15,657 $11,975 $27,632 
Pension Service Cost602 1,763 2,365 
Depreciation Expense293 1,659 1,952 
Income from Operations before Amortization of Intangible Assets$14,762 $8,553 $23,315 
Capital Expenditures$1,194 $13,340 $14,534 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations. Cost of revenue excludes charges related to depreciation, which is shown separately.
(3)Other segment items for CSI include indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
27


The Company’s segment information is as follows:
Three Months Ended September 30, 2025
(in thousands)EducationTelevision BroadcastingHealthcareManufacturingAutomotiveTotal Segments
Operating Revenues$472,662 $105,087 $208,415 $124,257 $285,228 $1,195,649 
Reconciliation of Revenue
Other Businesses and Corporate Office Revenues (1)
83,835 
Intersegment Elimination(625)
Total Consolidated Revenues$1,278,859 
Less: Significant Expenses (2)
Cost of Revenue (3)
187,485 130,564 88,082 243,239 649,370 
Payroll and Fringe Benefits Expense (4)
122,056 26,218 20,233 168,507 
Occupancy Expense26,486 1,978 28,464 
Advertising and Marketing Expense18,465 18,465 
Networking and Programming Expense30,943 30,943 
Management Services (5)
2,075 2,075 
Other Segment Items (6)
56,311 15,720 51,431 20,953 9,118 153,533 
EBITDAP
$61,859 $32,206 $26,420 $15,222 $8,585 $144,292 
Pension Service Cost4,318 1,475 2,496 866 (1)9,154 
Depreciation Expense7,085 2,597 1,837 3,219 1,718 16,456 
Income from Operations before Amortization of Intangible Assets and Impairment of Intangible and Other Long-Lived Assets$50,456 $28,134 $22,087 $11,137 $6,868 $118,682 
Other Businesses (7)
(21,949)
Corporate Costs(17,670)
Amortization of Intangible Assets(9,692)
Impairment of Intangible and Other Long-Lived Assets(2,235)
Income from Operations$67,136 
Equity in Earnings of Affiliates, Net15,780 
Interest Expense, Net(15,700)
Non-Operating Pension and Postretirement Benefit Income, Net31,047 
Gain on Marketable Equity Securities, Net84,768 
Other Income, Net7 
Income Before Income Taxes$183,038 
Capital Expenditures$3,624 $1,288 $5,138 $1,591 $2,179 $13,820 
Reconciliation of Capital Expenditures
Other Businesses and Corporate Office Capital Expenditures (8)
6,356 
Total Capital Expenditures$20,176 
(1)Revenue from segments below the quantitative thresholds is attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
(2)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(3)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(4)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(5)Management and operating services provided by Christopher J. Ourisman and his team of industry professionals.
(6)Other segment items for each reportable segment include:
(a)Education (includes Kaplan International, Kaplan Higher Education and Kaplan Supplemental Education) - training and employment expense, travel meals and entertainment expense, operating fees and other G&A expenses.
(b)Television Broadcasting - other broadcast expenses, facilities expenses, third-party commission costs and other SG&A expenses.
(c)Healthcare - indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
(d)Manufacturing - payroll and fringe benefits expense (SG&A) and other SG&A expenses.
(e)Automotive - advertising and marketing expense and other G&A expenses.
(7)Profit or loss from operating segments below the quantitative thresholds attributable to Other Businesses as described above. These operating segments did not meet any of the quantitative thresholds for determining reportable segments.
(8)Capital Expenditures from operating segments below the quantitative thresholds are attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
28


The Company’s education division segment information is as follows:
Three Months Ended September 30, 2025
(in thousands)Kaplan InternationalHigher EducationSupplemental EducationKaplan Corporate and OtherIntersegment EliminationTotal Education
Operating Revenues$294,292 $92,162 $86,679 $280 $(751)$472,662 
Less: Significant Expenses (1)
Cost of Revenue (2)
106,644 67,237 14,293 (689)187,485 
Payroll and Fringe Benefits Expense (3)
74,935 5,881 34,892 6,390 (42)122,056 
Occupancy Expense25,772 183 213 328 (10)26,486 
Advertising and Marketing Expense7,933 1,733 8,729 70 18,465 
Other Segment Items (4)
43,901 282 10,952 1,224 (48)56,311 
EBITDAP
$35,107 $16,846 $17,600 $(7,732)$38 $61,859 
Pension Service Cost142 1,849 1,929 398 4,318 
Depreciation Expense6,072 314 692 7 7,085 
Income (Loss) from Operations before Amortization of Intangible Assets$28,893 $14,683 $14,979 $(8,137)$38 $50,456 
Capital Expenditures$2,470 $163 $975 $16 $3,624 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(3)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(4)Other segment items for each reportable segment include:
(a)Kaplan international - travel meals and entertainment expense, training and employment expense, operating fees and other G&A expenses.
(b)Higher education - training and employment expense, operating fees and other G&A expenses.
(c)Supplemental education - training and employment expense, operating fees and other G&A expenses.
The Company’s healthcare division segment information is as follows:
Three Months Ended September 30, 2025
(in thousands)CSIOther HealthcareTotal Healthcare
Operating Revenues$120,382 $88,033 $208,415 
Less: Significant Expenses (1)
Cost of Revenue (2)
91,710 38,854 130,564 
Other Segment Items (3)
15,049 36,382 51,431 
EBITDAP
$13,623 $12,797 $26,420 
Pension Service Cost— 2,496 2,496 
Depreciation Expense186 1,651 1,837 
Income from Operations before Amortization of Intangible Assets$13,437 $8,650 $22,087 
Capital Expenditures$365 $4,773 $5,138 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations. Cost of revenue excludes charges related to depreciation, which is shown separately.
(3)Other segment items for CSI include indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
29


The Company’s segment information is as follows:
Nine Months Ended September 30, 2026
(in thousands)EducationTelevision BroadcastingHealthcareManufacturingAutomotiveTotal Segments
Operating Revenues$1,262,569 $346,487 $717,243 $405,915 $868,036 $3,600,250 
Reconciliation of Revenue
Other Businesses and Corporate Office Revenues (1)
266,487 
Intersegment Elimination(2,202)
Total Consolidated Revenues$3,864,535 
Less: Significant Expenses (2)
Cost of Revenue (3)
498,211 471,514 295,336 733,998 1,999,059 
Payroll and Fringe Benefits Expense (4)
339,286 81,013 61,154 481,453 
Occupancy Expense75,864 6,082 81,946 
Advertising and Marketing Expense57,261 57,261 
Networking and Programming Expense88,106 88,106 
Management Services (5)
6,940 6,940 
Other Segment Items (6)
119,428 48,790 168,519 62,523 31,259 430,519 
EBITDAP
$172,519 $128,578 $77,210 $48,056 $28,603 $454,966 
Pension Service Cost13,666 4,661 5,894 3,727 102 28,050 
Depreciation Expense17,237 6,952 5,779 9,027 5,775 44,770 
Income from Operations before Amortization of Intangible Assets and Impairment of Goodwill and Asset Group Held for Sale$141,616 $116,965 $65,537 $35,302 $22,726 $382,146 
Other Businesses (7)
(61,602)
Corporate Costs(56,719)
Amortization of Intangible Assets(17,808)
Impairment of Goodwill and Asset Group Held for Sale(19,029)
Income from Operations$226,988 
Equity in Earnings of Affiliates, Net11,397 
Interest Expense, Net(43,221)
Non-Operating Pension and Postretirement Benefit Income, Net248,323 
Gain on Marketable Equity Securities, Net17,929 
Other Expense, Net(4,146)
Income Before Income Taxes$457,270 
Capital Expenditures$14,430 $5,908 $20,267 $7,568 $10,473 $58,646 
Reconciliation of Capital Expenditures
Other Businesses and Corporate Office Capital Expenditures (8)
21,535 
Total Capital Expenditures$80,181 
(1)Revenue from segments below the quantitative thresholds is attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
(2)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(3)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(4)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(5)Management and operating services provided by Christopher J. Ourisman and his team of industry professionals.
(6)Other segment items for each reportable segment include:
(a)Education (includes Kaplan International, Kaplan Higher Education and Kaplan Supplemental Education) - training and employment expense, travel meals and entertainment expense, operating fees and other G&A expenses.
(b)Television Broadcasting - other broadcast expenses, facilities expenses, third-party commission costs and other SG&A expenses.
(c)Healthcare - indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
(d)Manufacturing - payroll and fringe benefits expense (SG&A) and other SG&A expenses.
(e)Automotive - advertising and marketing expense and other G&A expenses.
(7)Profit or loss from operating segments below the quantitative thresholds attributable to Other Businesses as described above. These operating segments did not meet any of the quantitative thresholds for determining reportable segments.
(8)Capital Expenditures from operating segments below the quantitative thresholds are attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
30


The Company’s education division segment information is as follows:
Nine Months Ended September 30, 2026
(in thousands)Kaplan InternationalHigher EducationSupplemental EducationKaplan Corporate and OtherIntersegment EliminationTotal Education
Operating Revenues$754,145 $272,561 $237,145 $924 $(2,206)$1,262,569 
Less: Significant Expenses (1)
Cost of Revenue (2)
265,681 195,171 38,279 (920)498,211 
Payroll and Fringe Benefits Expense (3)
216,073 11,618 99,188 12,777 (370)339,286 
Occupancy Expense72,619 486 2,465 1,105 (811)75,864 
Advertising and Marketing Expense22,885 5,386 28,732 258 57,261 
Other Segment Items (4)
81,224 778 34,662 2,772 (8)119,428 
EBITDAP
$95,663 $59,122 $33,819 $(15,988)$(97)$172,519 
Pension Service Cost176 5,936 6,063 1,491 13,666 
Depreciation Expense13,945 945 2,317 30 17,237 
Income (Loss) from Operations before Amortization of Intangible Assets and Impairment of Goodwill and Asset Group Held for Sale$81,542 $52,241 $25,439 $(17,509)$(97)$141,616 
Capital Expenditures$11,181 $1,705 $1,525 $19 $14,430 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(3)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(4)Other segment items for each reportable segment include:
(a)Kaplan international - travel meals and entertainment expense, training and employment expense, operating fees and other G&A expenses.
(b)Higher education - training and employment expense, operating fees and other G&A expenses.
(c)Supplemental education - training and employment expense, operating fees and other G&A expenses.
The Company’s healthcare division segment information is as follows:
Nine Months Ended September 30, 2026
(in thousands)CSIOther HealthcareTotal Healthcare
Operating Revenues$428,593 $288,650 $717,243 
Less: Significant Expenses (1)
Cost of Revenue (2)
330,748 140,766 471,514 
Other Segment Items (3)
62,743 105,776 168,519 
EBITDAP
$35,102 $42,108 $77,210 
Pension Service Cost602 5,292 5,894 
Depreciation Expense887 4,892 5,779 
Income from Operations before Amortization of Intangible Assets$33,613 $31,924 $65,537 
Capital Expenditures$3,981 $16,286 $20,267 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations. Cost of revenue excludes charges related to depreciation, which is shown separately.
(3)Other segment items for CSI include indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
31


The Company’s segment information is as follows:
Nine Months Ended September 30, 2025
(in thousands)EducationTelevision BroadcastingHealthcareManufacturingAutomotiveTotal Segments
Operating Revenues$1,334,206 $314,625 $584,375 $318,480 $851,791 $3,403,477 
Reconciliation of Revenue
Other Businesses and Corporate Office Revenues (1)
258,943 
Intersegment Elimination(1,874)
Total Consolidated Revenues$3,660,546 
Less: Significant Expenses (2)
Cost of Revenue (3)
512,589 352,631 223,187 725,185 1,813,592 
Payroll and Fringe Benefits Expense (4)
356,003 80,800 59,289 496,092 
Occupancy Expense83,432 5,706 89,138 
Advertising and Marketing Expense58,876 58,876 
Networking and Programming Expense93,507 93,507 
Management Services (5)
6,186 6,186 
Other Segment Items (6)
147,599 44,850 153,174 55,076 27,560 428,259 
EBITDAP
$175,707 $95,468 $78,570 $40,217 $27,865 $417,827 
Pension Service Cost12,954 4,426 7,488 2,596 47 27,511 
Depreciation Expense22,261 7,850 5,346 8,576 5,155 49,188 
Income from Operations before Amortization of Intangible Assets and Impairment of Intangible and Other Long-Lived Assets$140,492 $83,192 $65,736 $29,045 $22,663 $341,128 
Other Businesses (7)
(77,062)
Corporate Costs(49,714)
Amortization of Intangible Assets(24,757)
Impairment of Intangible and Other Long-Lived Assets(2,235)
Income from Operations$187,360 
Equity in Earnings of Affiliates, Net10,466 
Interest Expense, Net(111,322)
Non-Operating Pension and Postretirement Benefit Income, Net94,266 
Gain on Marketable Equity Securities, Net117,026 
Other Expense, Net(20,514)
Income Before Income Taxes$277,282 
Capital Expenditures$13,741 $2,770 $10,204 $7,650 $4,151 $38,516 
Reconciliation of Capital Expenditures
Other Businesses and Corporate Office Capital Expenditures (8)
15,583 
Total Capital Expenditures$54,099 
(1)Revenue from segments below the quantitative thresholds is attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
(2)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(3)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(4)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(5)Management and operating services provided by Christopher J. Ourisman and his team of industry professionals.
(6)Other segment items for each reportable segment include:
(a)Education (includes Kaplan International, Kaplan Higher Education and Kaplan Supplemental Education) - training and employment expense, travel meals and entertainment expense, operating fees and other G&A expenses.
(b)Television Broadcasting - other broadcast expenses, facilities expenses, third-party commission costs and other SG&A expenses.
(c)Healthcare - indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
(d)Manufacturing - payroll and fringe benefits expense (SG&A) and other SG&A expenses.
(e)Automotive - advertising and marketing expense and other G&A expenses.
(7)Profit or loss from operating segments below the quantitative thresholds attributable to Other Businesses as described above. These operating segments did not meet any of the quantitative thresholds for determining reportable segments.
(8)Capital Expenditures from operating segments below the quantitative thresholds are attributable to Other Businesses and the Corporate Office, as described above. None of these operating segments meet the quantitative thresholds for determining reportable segments.
32


The Company’s education division segment information is as follows:
Nine Months Ended September 30, 2025
(in thousands)Kaplan InternationalHigher EducationSupplemental EducationKaplan Corporate and OtherIntersegment EliminationTotal Education
Operating Revenues$827,719 $265,387 $242,243 $315 $(1,458)$1,334,206 
Less: Significant Expenses (1)
Cost of Revenue (2)
284,162 190,620 39,165 (1,358)512,589 
Payroll and Fringe Benefits Expense (3)
222,257 15,600 101,404 16,806 (64)356,003 
Occupancy Expense80,337 543 2,099 463 (10)83,432 
Advertising and Marketing Expense24,876 5,741 27,939 320 58,876 
Other Segment Items (4)
107,753 722 35,419 3,717 (12)147,599 
EBITDAP
$108,334 $52,161 $36,217 $(20,991)$(14)$175,707 
Pension Service Cost428 5,546 5,788 1,192 12,954 
Depreciation Expense19,014 1,153 2,076 18 22,261 
Income (Loss) from Operations before Amortization of Intangible Assets$88,892 $45,462 $28,353 $(22,201)$(14)$140,492 
Capital Expenditures$8,970 $828 $3,920 $23 $13,741 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations or align across reportable segments. Cost of revenue excludes charges related to depreciation, which is shown separately above.
(3)Excludes pension service cost, which is shown separately above. Excludes any payroll and related benefits costs captured in cost of revenue.
(4)Other segment items for each reportable segment include:
(a)Kaplan international - travel meals and entertainment expense, training and employment expense, operating fees and other G&A expenses.
(b)Higher education - training and employment expense, operating fees and other G&A expenses.
(c)Supplemental education - training and employment expense, operating fees and other G&A expenses.
The Company’s healthcare division segment information is as follows:
Nine Months Ended September 30, 2025
(in thousands)CSIOther HealthcareTotal Healthcare
Operating Revenues$324,045 $260,330 $584,375 
Less: Significant Expenses (1)
Cost of Revenue (2)
237,731 114,900 352,631 
Other Segment Items (3)
48,625 104,549 153,174 
EBITDAP
$37,689 $40,881 $78,570 
Pension Service Cost— 7,488 7,488 
Depreciation Expense545 4,801 5,346 
Income from Operations before Amortization of Intangible Assets$37,144 $28,592 $65,736 
Capital Expenditures$901 $9,303 $10,204 
(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(2)Cost of revenue reflects the amounts reported and provided to the CODM and does not necessarily reconcile to the Company's Consolidated Statement of Operations. Cost of revenue excludes charges related to depreciation, which is shown separately.
(3)Other segment items for CSI include indirect costs (e.g. payroll and benefits expenses, G&A expenses) and other SG&A expenses.
33


Asset information for the Company’s business segments is as follows:
As of
(in thousands)September 30, 2026December 31, 2025
Identifiable Assets
Kaplan international$1,394,486 $1,551,682 
Higher education127,790 174,738 
Supplemental education235,040 247,181 
Kaplan corporate and other27,054 34,973 
Education1,784,370 2,008,574 
Television broadcasting371,459 393,097 
CSI224,674 128,170 
Other healthcare202,855 227,457 
Healthcare427,529 355,627 
Manufacturing563,192 535,006 
Automotive600,900 582,715 
Total Segments3,747,450 3,875,019 
Other businesses376,604 357,408 
Corporate office104,513 79,389 
Investments in Marketable Equity Securities1,069,741 1,081,938 
Investments in Affiliates202,339 229,565 
Prepaid Pension Cost2,789,352 2,772,394 
Total Assets$8,289,999 $8,395,713 
34


Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition.
This analysis should be read in conjunction with the condensed consolidated financial statements and the notes thereto.
Results of Operations
The Company reported net income attributable to common shares of $75.1 million ($17.60 per share) for the third quarter of 2026, compared to $122.9 million ($27.91 per share) for the third quarter of 2025.
Items included in the Company’s net income for the third quarter of 2026:
•a $15.0 million settlement gain related to a retiree annuity pension purchase (after-tax impact of $11.1 million, or $2.59 per share);
•$3.2 million in non-operating expenses related to Separation Incentive Programs (SIPs) and a Voluntary Retirement Incentive Program (VRIP) (after-tax impact of $2.4 million, or $0.55 per share);
•a $0.1 million reduction to interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $0.1 million, or $0.03 per share);
•$15.0 million in net losses on marketable equity securities (after-tax impact of $11.2 million, or $2.62 per share);
•$6.3 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $4.7 million, or $1.10 per share);
•a non-operating loss of $0.6 million from the impairment of equity and cost method investments (after-tax impact of $0.4 million, or $0.10 per share);
•$1.5 million in income tax expense related to the KLG business ($0.34 per share); and
•a $3.9 million income tax benefit recorded in connection with global minimum income tax obligations in non-U.S. jurisdictions ($0.92 per share).
Items included in the Company’s net income for the third quarter of 2025:
•$2.2 million in intangible and other long-lived asset impairment charges at healthcare, automotive and other businesses (after-tax impact of $1.7 million, or $0.39 per share);
•$2.5 million in non-operating expenses related to SIPs (after-tax impact of $1.9 million, or $0.43 per share);
•$0.7 million in interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $6.9 million, or $1.57 per share);
•$84.8 million in net gains on marketable equity securities (after-tax impact of $63.0 million, or $14.31 per share);
•$5.8 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $4.3 million, or $0.98 per share); and
•a net non-operating gain of $17.1 million from earnings and impairment of equity and cost method investments (after-tax impact of $12.7 million, or $2.89 per share).
Revenue for the third quarter of 2026 was $1,326.0 million, up 4% from $1,278.9 million in the third quarter of 2025. The Company reported operating income of $85.5 million for the third quarter of 2026, compared to $67.1 million for the third quarter of 2025. Revenues and operating results increased at television broadcasting, healthcare, manufacturing, automotive and other businesses, partially offset by a decline at education.

35


For the first nine months of 2026, the Company reported net income attributable to common shares of $385.3 million ($88.92 per share), compared to $183.6 million ($41.75 per share) for the first nine months of 2025.
Items included in the Company’s net income for the first nine months of 2026:
•$24.2 million of impairment charges and loss on sale related to KLG (after-tax impact of $24.8 million, or $5.72 per share);
•a $151.9 million settlement gain related to a retiree annuity pension purchase (after-tax impact of $112.4 million, or $25.94 per share);
•$11.1 million in non-operating expenses related to SIPs and VRIPs (after-tax impact of $8.2 million, or $1.90 per share);
•a $1.0 million reduction to interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $0.9 million, or $0.20 per share);
•$17.9 million in net gains on marketable equity securities (after-tax impact of $13.3 million, or $3.08 per share);
•$6.8 million in net earnings of affiliates whose operations are not managed by the Company (after-tax impact of $5.0 million, or $1.16 per share);
•net non-operating losses of $5.9 million from impairments and sales of equity and cost method investments (after-tax impact of $4.4 million, or $1.02 per share);
•a $68.1 million income tax benefit related to the KLG business ($15.72 per share); and
•$15.3 million in income tax expense recorded in connection with global minimum income tax obligations in non- U.S. jurisdictions ($3.52 per share).
Items included in the Company’s net income for the first nine months of 2025:
•$2.2 million in intangible and other long-lived asset impairment charges (after-tax impact of $1.7 million, or $0.39 per share);
•$9.2 million in non-operating expenses related to SIPs (after-tax impact of $6.8 million, or $1.55 per share);
•$68.3 million in interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $60.8 million, or $13.83 per share);
•$117.0 million in net gains on marketable equity securities (after-tax impact of $87.0 million, or $19.79 per share);
•$18.1 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $13.5 million, or $3.06 per share); and
•net non-operating gains of $4.4 million from earnings and impairment of equity and cost method investments (after-tax impact of $3.3 million, or $0.74 per share).
Revenue for the first nine months of 2026 was $3,864.5 million, up 6% from $3,660.5 million in the first nine months of 2025. The Company reported operating income of $227.0 million for the first nine months of 2026, compared to $187.4 million for the first nine months of 2025. Revenues and operating results increased at television broadcasting, healthcare, manufacturing, automotive and other businesses, partially offset by a decline at education.
Division Results
Education
Education division revenue totaled $404.3 million for the third quarter of 2026, down 14% from $472.7 million for the same period of 2025. Kaplan reported operating income of $39.3 million for the third quarter of 2026, compared to $49.1 million for the third quarter of 2025.
For the first nine months of 2026, education division revenue totaled $1,262.6 million, down 5% from $1,334.2 million for the same period of 2025. Kaplan reported operating income of $121.9 million for the first nine months of 2026, compared to $135.3 million for the first nine months of 2025.
36


A summary of Kaplan’s operating results is as follows:
Three Months EndedNine Months Ended
  September 30  September 30  
(in thousands)20262025% Change20262025% Change
Revenue            
Kaplan international$230,134 $294,292 (22)$754,145 $827,719 (9)
Higher education93,865 92,162 2 272,561 265,387 3 
Supplemental education80,805 86,679 (7)237,145 242,243 (2)
Kaplan corporate and other369 280 32 924 315 — 
Intersegment elimination(891)(751)— (2,206)(1,458)— 
  $404,282 $472,662 (14)$1,262,569 $1,334,206 (5)
Operating Income (Loss)            
Kaplan international$17,292 $28,893 (40)$81,542 $88,892 (8)
Higher education17,904 14,683 22 52,241 45,462 15 
Supplemental education9,655 14,979 (36)25,439 28,353 (10)
Kaplan corporate and other(5,392)(8,137)34 (17,509)(22,201)21 
Amortization of intangible assets(84)(1,404)94 (641)(5,222)88 
Impairment of goodwill and asset group held for sale— — — (19,029)— — 
Intersegment elimination(87)38 — (97)(14)— 
  $39,288 $49,052 (20)$121,946 $135,270 (10)
In the first quarter of 2026, the Company entered into an agreement to sell KLG included in Kaplan International and recorded a $19.0 million pre-tax impairment charge. Excluding the impairment charge, Kaplan’s operating income was up in the first nine months of 2026. The KLG transaction closed on May 1, 2026 and the Company recorded a $5.2 million non-operating pre-tax loss on the sale of the business in the second quarter of 2026.
Kaplan International includes postsecondary education and professional training businesses largely outside the United States (U.S.). Kaplan International revenue decreased 22% for the third quarter of 2026 (23% decrease on a constant currency basis) and decreased 9% for the first nine months of 2026 (12% decrease on a constant currency basis) due to the sale of KLG and broad declines at Pathways, partially offset by increases at Singapore and UK Professional. Kaplan International reported operating income of $17.3 million in the third quarter of 2026, down from $28.9 million in the third quarter of 2025. The decline in operating results was due to broad declines at the Pathways businesses, particularly in the U.S., and meaningful operating income at KLG in the third quarter of 2025 from the seasonally high summer enrollment months. Improved results at UK Professional, Singapore and Kaplan Higher Education UK (formerly Kaplan Open Learning) partially offset this decline. Operating income declined to $81.5 million in the first nine months of 2026, from $88.9 million in the first nine months of 2025. The decline in operating results was from broad declines at the Pathways businesses and increased losses at KLG. Partially offsetting the decline, operating results increased at Singapore, UK Professional, Kaplan Higher Education UK (formerly Kaplan Open Learning) and Australia.
Higher Education includes the results of Kaplan as a service provider to higher education institutions. Higher Education revenue increased 2% and 3% for the third quarter and first nine months of 2026, respectively, due primarily to an increase in the Purdue Global fee recorded. Enrollments at Purdue Global, the largest institutional client, increased 4% for the first nine months of 2026 compared to the first nine months of 2025. For the third quarters and first nine months of 2026 and 2025, Kaplan recorded the full fee from Purdue Global. The Company will continue to assess the fee it records from Purdue Global on a quarterly basis to make a determination as to whether to record all or part of the fee in the future and whether to adjust fee amounts recognized in earlier periods. Higher Education operating results improved in the third quarter and first nine months of 2026 due to an increase in the Purdue Global fee recorded, and a decline in higher education development costs.
Supplemental Education includes Kaplan’s standardized test preparation programs and domestic professional and other continuing education businesses. Supplemental Education revenue was down 2% for the first nine months of 2026 due to declines in the retail channel of its exam preparation programs; offset in part by growth in the institutional channel. Operating results decreased in the third quarter and first nine months of 2026 due to revenue declines.
Kaplan corporate and other represents unallocated expenses of Kaplan’s corporate office, other minor businesses and certain shared activities.
In the third quarter of 2026, the Company offered a SIP to certain employees at Supplemental Education, Higher Education and Kaplan corporate; $1.3 million in related non-operating pension expense was recorded in the third quarter of 2026. In the second quarter of 2026, the Company offered a SIP to certain employees at Supplemental Education, Higher Education, Kaplan International and Kaplan corporate; $1.2 million in related non-operating
37


pension expense was recorded in the second quarter of 2026. In the first quarter of 2026, the Company offered a SIP to certain employees at Kaplan International, Higher Education and Supplemental Education; $1.9 million in related non-operating pension expense was recorded in the first quarter of 2026. In the third quarter of 2025, the Company offered a SIP to certain employees at Higher Education and Supplemental Education; $1.3 million in related non-operating pension expense was recorded in the third quarter of 2025. In the second quarter of 2025, the Company offered a SIP to certain employees at Higher Education and Supplemental Education; $0.7 million in related non-operating pension expense was recorded in the second quarter of 2025. These programs were funded from the assets of the Company’s pension plan.
In the third quarter of 2026, Kaplan entered into an agreement to sell Dublin Business School (DBS) to China Chunlai Education Group Co., Ltd., a provider of private higher education in China. At September 30, 2026, the Company classified the assets and liabilities of DBS as held for sale. The transaction closed on October 27, 2026. Under the terms of the Share Purchase Agreement, Kaplan sold all of the outstanding shares of Accountancy & Business College (Ireland) Limited, which operates DBS, together with certain intellectual property, for $127.5 million.
Television Broadcasting
A summary of television broadcasting’s operating results is as follows:
Three Months EndedNine Months Ended
  September 30  September 30  
(in thousands)20262025% Change20262025% Change
Revenue$125,304 $105,087 19 $346,487 $314,625 10 
Operating Income48,459 26,774 81 112,885 79,112 43 
Graham Media Group owns seven television stations located in Houston, TX; Detroit, MI; Orlando, FL; San Antonio, TX; Jacksonville, FL; and Roanoke, VA, as well as SocialNewsDesk, a provider of social media management tools designed to connect newsrooms with their users.
Revenue at the television broadcasting division increased 19% to $125.3 million in the third quarter of 2026, from $105.1 million in the same period of 2025. The revenue increase is due to a $29.3 million increase in political advertising revenue, partially offset by a $1.4 million decrease in retransmission revenue and declines in local and digital advertising revenue. Operating income for the third quarter of 2026 was up 81% to $48.5 million, from $26.8 million in the same period of 2025, due to higher revenues.
Revenue at the television broadcasting division was up 10% to $346.5 million in the first nine months of 2026, from $314.6 million in the same period of 2025. The revenue increase is due to a $45.0 million increase in political advertising revenue and increases from winter Olympics and Super Bowl advertising revenue at the Company’s NBC affiliates in the first quarter of 2026, partially offset by a $6.6 million decrease in retransmission revenue and declines in local and digital advertising revenue. Operating income for the first nine months of 2026 was up 43% to $112.9 million, from $79.1 million in the same period of 2025, due to higher revenues.
While per subscriber rates from cable, satellite and OTT providers have grown, overall cable and satellite subscribers are down due to cord cutting, resulting in retransmission revenue net of network fees in 2026 expected to decline compared with 2025, and this trend is expected to continue.
In the first and second quarters of 2026, the Company offered SIPs to certain employees at the television broadcasting division; $0.6 million and $0.3 million, respectively, in related non-operating pension expense was recorded. In the second and third quarters of 2025, the Company offered SIPs to certain employees at the television broadcasting division; $0.1 million in related non-operating pension expense was recorded. These programs were funded from the assets of the Company’s pension plan.
In May 2026, the Company’s television station in Orlando (WKMG) entered into a new network affiliation agreement with CBS that covers the period July 1, 2026 through December 31, 2027. In March 2026, the Company’s television station in San Antonio (KSAT) entered into a new network affiliation agreement with ABC that covers the period April 1, 2026 through March 31, 2030.
Healthcare
Healthcare division revenue totaled $260.3 million for the third quarter of 2026, up 25% from $208.4 million for the same period of 2025. Healthcare reported operating income of $23.2 million for the third quarter of 2026, compared to $21.0 million for the third quarter of 2025.
38


Healthcare division revenue totaled $717.2 million for the first nine months of 2026, up 23% from $584.4 million for the same period of 2025. Healthcare reported operating income of $65.3 million for the first nine months of 2026, compared to $64.4 million for the same period of 2025.
A summary of healthcare division’s operating results is as follows:
  Three Months EndedNine Months Ended  
September 30September 30
(in thousands)20262025% Change20262025% Change
Revenue
CSI$162,289 $120,382 35 $428,593 $324,045 32 
Other Healthcare97,963 88,033 11 288,650 260,330 11 
$260,252 $208,415 25 $717,243 $584,375 23 
Operating Income
CSI$14,741 $13,397 10 $33,551 $37,037 (9)
Other Healthcare8,503 7,595 12 31,729 27,369 16 
$23,244 $20,992 11 $65,280 $64,406 1 
The healthcare group provides nursing care and prescription services for patients receiving in-home infusion treatments through its 93.4% interest in CSI Pharmacy Holding Company, LLC (CSI). In August 2025, CSI purchased Pine Drug Holdings, LLC and was issued a California pharmacy license, with dispensing operations commencing late in the fourth quarter of 2025. CSI revenue increased 35% and 32% for the third quarter and first nine months of 2026, respectively, from continued expansion of treatment offerings and patient service areas. Operating results were up 10% in the third quarter of 2026 due to improved operating margins for certain products from the first half of 2026, partially offset by increased incentive compensation expense. Operating results were down for the first nine months of 2026 due to various operational investments including expanding CSI’s pharmacy facility locations; lower operating margins for certain products compared with the first nine months of 2025; and increased incentive compensation expense. The Company expects continued revenue growth at CSI for the remainder of 2026 compared with 2025.
Healthcare also includes Graham Healthcare Group (GHG), which provides home health and hospice services in seven states. In March 2026, GHG acquired Covenant Home Health of Havertown, PA, a home health provider in Eastern Pennsylvania. Healthcare also includes four other businesses: Clarus (provides call management SaaS-based solution for physician groups and hospitals), Impact Medical (an allergy, asthma and immunology physician practice), Skin Clique (a concierge provider of aesthetics products and services) and Surpass Behavioral Health (provides therapy for autism patients). Revenue increased in other healthcare by 11% in both the third quarter and first nine months of 2026 from growth in home health and hospice services and the other healthcare businesses. Operating results improved at home health and hospice in the third quarter and first nine months of 2026, partly due to a reduction in pension expense. Overall, operating results declined at the four other healthcare businesses in the third quarter and first nine months of 2026.
In the third quarter of 2025, home health and hospice recorded $1.0 million of lease impairment charges.
The Company also holds interests in four home health and hospice joint ventures managed by GHG, whose results are included in equity in earnings of affiliates in the Company’s Condensed Consolidated Statements of Operations. The Company recorded equity in earnings of $2.9 million for each of the third quarters of 2026 and 2025 from these joint ventures. The Company recorded equity in earnings of $10.0 million and $9.6 million for the first nine months of 2026 and 2025, respectively, from these joint ventures.
Manufacturing
A summary of manufacturing’s operating results is as follows:
Three Months EndedNine Months Ended
  September 30  September 30  
(in thousands)20262025% Change20262025% Change
Revenue$147,601 $124,257 19 $405,915 $318,480 27 
Operating Income
8,998 6,695 34 24,099 19,741 22 
Manufacturing includes four businesses: Hoover, a supplier of pressure impregnated kiln-dried lumber and plywood products for fire retardant and preservative applications, and aluminum cladding products for the non-residential market; Dekko, a manufacturer of electrical workspace solutions, architectural lighting and electrical components and assemblies; Joyce, a manufacturer of screw jacks and other linear motion systems; and Forney, a global supplier of products and systems that control and monitor combustion processes in electric utility and industrial applications. On July 15, 2025, Hoover acquired Arconic Architectural Products, LLC, a wholly-owned subsidiary of
39


Arconic Corporation (operating as Hoover Architectural Solutions), which manufactures aluminum cladding products and operates within the broader non-residential materials space from its facility in Eastman, GA. A significant portion of the purchase price was funded by the Company’s assumption of $107.5 million in net pension obligations.
Manufacturing revenues increased 19% and 27% in the third quarter and first nine months of 2026, respectively, due to increased revenues at Hoover, Joyce and Forney, partially offset by lower revenues at Dekko. The revenue increase at Hoover for the first nine months of 2026 is due largely to the Hoover Architectural Solutions business acquisition. Excluding the acquisition, overall volumes increased in the third quarter and first nine months of 2026. Hoover results included wood gains on inventory sales in both the third quarter and first nine months of 2026 and 2025. Manufacturing operating results improved in the third quarter of 2026 due largely to significant growth at Forney, and growth at Joyce. Manufacturing operating results increased in the first nine months of 2026 due to significant growth at Joyce and Forney, and improved results at Dekko. The increase was partially offset by an overall decline at Hoover from increased intangible asset amortization and transition costs related to the Arconic acquisition.
In the third quarter of 2026, the Company offered a SIP to certain employees at Dekko; $0.1 million in related non-operating pension expense was recorded. In the second quarter of 2026, the Company offered a VRIP to certain employees at Dekko; $2.0 million in related non-operating pension expense was recorded. In the first quarter of 2026, the Company offered a SIP to certain employees at Dekko and Joyce; $0.2 million in related non-operating pension expense was recorded. In the third quarter of 2025, the Company offered a SIP to certain employees at Joyce; $0.1 million in related non-operating pension expense was recorded. These programs were funded from the assets of the Company’s pension plan.
Automotive
A summary of automotive’s operating results is as follows:
Three Months EndedNine Months Ended
  September 30  September 30  
(in thousands)20262025% Change20262025% Change
Revenue$299,060 $285,228 5 $868,036 $851,791 2 
Operating Income9,338 6,308 48 22,711 22,093 3 
Automotive includes eight automotive dealerships in the Washington, DC metropolitan area and Richmond, VA: Ourisman Lexus of Rockville, Ourisman Honda of Tysons Corner, Ourisman Ford of Manassas, Toyota of Woodbridge, Ourisman Chrysler-Dodge-Jeep-Ram of Woodbridge, Ourisman Toyota of Richmond, and Ourisman Kia of Bethesda. In addition, on October 21, 2025, the Company acquired a Honda automotive dealership in Woodbridge, VA, including the real property for the dealership operations. Automotive also includes Roda, which provides valet automotive repair services in the Washington, DC metropolitan area. Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships, and his team of industry professionals operate and manage the dealerships; the Company holds a 90% stake.
The Company ceased operations of the Ourisman Jeep of Bethesda dealership, which was closed in early September 2025. As a result, the Company recorded a $0.6 million intangible asset impairment charge on the related franchise agreement in the third quarter of 2025.
Revenues for the third quarter of 2026 increased 5% due partly to increased revenues from the Honda of Woodbridge dealership acquisition, offset by the closure of the Ourisman Jeep of Bethesda dealership in September 2025. Excluding these dealerships, revenues were down mostly from declines in new and used vehicle sales, partially offset by sales growth for services and parts. Operating results were up in the third quarter of 2026 due largely to earnings from the Honda of Woodbridge dealership acquisition, the closure of the Ourisman Jeep of Bethesda dealership, and higher overall gross profits on new vehicles and services and parts, partially offset by lower gross profits on used vehicles.
Revenues for the first nine months of 2026 increased 2%, due partly to increased revenues from the Honda of Woodbridge dealership acquisition, offset by the closure of the Ourisman Jeep of Bethesda dealership in September 2025. Excluding these dealerships, revenues were down mostly from declines in new and used vehicle sales, partially offset by sales growth for services and parts. Operating results were up slightly in the first nine months of 2026 due largely to earnings from the Honda of Woodbridge dealership acquisition, the closure of the Ourisman Jeep of Bethesda dealership, and higher overall gross profits on services and parts, partially offset by lower gross profits on new and used vehicles.
40


Other Businesses
A summary of revenue by category for other businesses:
Three Months EndedNine Months Ended
September 30%September 30%
20262025Change20262025Change
Operating Revenues
Specialty (1)
$40,642 $36,517 11 $125,467 $118,030 6 
Retail (2)
31,112 27,539 13 88,797 80,918 10 
Media (3)
17,689 19,159 (8)49,945 58,134 (14)
$89,443 $83,215 7 $264,209 $257,082 3 
____________
(1)
Includes Clyde’s Restaurant Group (CRG), Decile and Supporting Cast
(2)
Includes Framebridge, Saatchi Art and Society6
(3)
Includes Slate, Foreign Policy, Code3, World of Good Brands (WGB) (sold in 2025) and City Cast
Overall, revenue from other businesses increased 3% in the first nine months of 2026. Specialty revenue increased due to revenue growth at CRG and Supporting Cast. Retail revenue increased due to revenue growth at Framebridge and Saatchi Art, partially offset by lower revenue at Society6. Media revenue declined due to the sale of WGB and lower revenue at Slate and Code3, partially offset by revenue growth at Foreign Policy and City Cast.
Overall, operating losses at other businesses were down in the first nine months of 2026, due to a reduction of losses from the sale of WGB and improved results at Society6, Saatchi Art, Code3, Decile, and Supporting Cast, partially offset by declines at CRG, Framebridge, Slate, City Cast and Foreign Policy.
Clyde’s Restaurant Group
CRG owns and operates 14 restaurants and entertainment venues in the Washington, DC metropolitan area, including Old Ebbitt Grill and The Hamilton. Revenue was up in the third quarter and first nine months of 2026. CRG reported an operating loss for the third quarter of 2026 and 2025, with improved results in the third quarter of 2026. CRG reported an operating profit for the first nine months of 2026 and 2025, with operating results down for 2026 due to severe weather conditions and the temporary closure of two restaurants and related repair work that was completed early in the first quarter of 2026.
In the second quarter of 2026, operations commenced under a Clyde’s licensing agreement at Dulles International Airport. CRG plans to open a new restaurant in Reston, VA in the fourth quarter of 2026.
Framebridge
Framebridge is a custom framing service company, headquartered in the Washington, DC metropolitan area, with 54 retail locations, and five manufacturing facilities in Kentucky, Virginia, Nevada (opened in the third quarter of 2025) and Massachusetts (opened in the third quarter of 2026). In the first nine months of 2026, Framebridge opened ten new retail stores. Framebridge plans to open additional stores and manufacturing facilities in the fourth quarter of 2026, and continues to actively explore other opportunities for further store and manufacturing expansion.
Revenues grew in the third quarter and first nine months of 2026 due to an increase in retail revenue from same-store sales growth and operating additional retail stores compared to the same periods in 2025, and a modest increase in online revenues. Framebridge is an investment stage business and reported significant operating losses in the first nine months of 2026 and 2025. Framebridge operating results include ongoing expansion investments from new retail store openings and manufacturing facilities.
In the third quarter of 2026, the Company offered a SIP to certain employees at Framebridge; $1.0 million in related non-operating pension expense was recorded. In the first quarter of 2026, the Company offered a SIP to certain employees at Framebridge; $0.2 million in related non-operating pension expense was recorded. These programs were funded from the assets of the Company’s pension plan.
Other
Other businesses also include Code3, a performance marketing agency focused on driving performance for brands through three core elements of digital success: media, creative and commerce; Slate and Foreign Policy, which publish online and print magazines and websites; Saatchi Art and Society6, which offer art and designs of various consumer products; and three investment stage businesses, Decile, City Cast and Supporting Cast. Saatchi Art, Supporting Cast, Foreign Policy, and City Cast reported revenue growth in the first nine months of 2026, while Society6, Slate, Code3 and Decile reported revenue declines. Losses from City Cast, Society6, Slate, Decile and
41


Saatchi Art in the first nine months of 2026 adversely affected operating results, while Foreign Policy, Supporting Cast and Code3 reported an operating profit.
In the third quarter of 2026, the Company offered a SIP to certain employees at Saatchi Art; $0.1 million in related non-operating pension expense was recorded. In the second quarter of 2026, the Company offered a SIP to certain employees at Code3 and Slate; $0.3 million in related non-operating pension expense was recorded. In the first quarter of 2026, the Company offered SIPs to certain employees at Slate and Code3; $1.0 million in related non-operating pension expense was recorded. In the third quarter of 2025, the Company offered SIPs to certain employees at Code3, Saatchi Art and Society6; $1.1 million in related non-operating pension expense was recorded. In the second quarter of 2025, the Company offered SIPs to certain employees at Code3, Saatchi Art, Society6, WGB and Decile; $5.2 million in related non-operating pension expense was recorded. In the first quarter of 2025, WGB offered a SIP; $0.6 million in related non-operating pension expense was recorded. These programs were funded from the assets of the Company’s pension plan.
Corporate Office
Corporate office includes the expenses of the Company’s corporate office and certain continuing obligations related to prior business dispositions. Corporate expenses were higher in the first nine months of 2026 due largely to increased costs related to employee healthcare and legal professional services.
In the third quarter of 2026, the Company offered a VRIP to certain employees at the Corporate office; $0.8 million in related non-operating pension expense was recorded. This program was funded from the assets of the Company’s pension plan.
Equity in Earnings (Losses) of Affiliates
At September 30, 2026, the Company held an approximate 25.6% interest in Intersection, a company that provides digital marketing and advertising services and products for cities, transit systems, airports, and other public and private spaces; and a 41.5% interest on a fully diluted basis in Realm. The Company also holds interests in several other affiliates, including a number of home health and hospice joint ventures managed by GHG and a joint venture managed by Kaplan. Overall, the Company recorded equity in losses of affiliates of $3.6 million for the third quarter of 2026, compared to earnings of $15.8 million for the third quarter of 2025. These amounts include $6.3 million and $5.8 million in net losses for the third quarter of 2026 and 2025, respectively, from affiliates whose operations are not managed by the Company. The 2026 amount also includes a $0.5 million impairment loss on one of the Company’s investment in affiliates. The 2025 amount includes a gain of $18.6 million in equity earnings related to the Company’s investment in Intersection.
The Company recorded equity in earnings of affiliates of $11.4 million for the first nine months of 2026, compared to $10.5 million for the first nine months of 2025. These amounts include $6.8 million in net earnings and $18.1 million in net losses for the first nine months of 2026 and 2025, respectively, from affiliates whose operations are not managed by the Company. The 2026 amount also includes $6.3 million impairment losses on the Company’s investment in Realm and one of the Company’s other investment in affiliates. The 2025 amount also includes a gain of $18.6 million in equity earnings related to the Company’s investment in Intersection.
Net Interest Expense and Related Balances
On November 24, 2025, the Company issued $500 million of 5.625% unsecured eight-year fixed-rate notes due December 1, 2033 (the Notes). Interest is paid semi-annually on June 1 and December 1. Also on November 24, 2025, the Company used the net proceeds from the sale of the Notes, together with the borrowings under the revolving credit agreement, to (i) redeem the $400 million of 5.75% unsecured notes due June 1, 2026, (ii) refinance outstanding revolving loans under the existing revolving credit facility, and (iii) repay all amounts outstanding under the Company’s existing $150 million term loan. On October 21, 2025, the automotive subsidiary borrowed $38.7 million under the delayed draw term loan to finance the acquisition of a Honda automotive dealership, including the real property for the dealership operations.
The Company incurred net interest expense of $14.2 million and $43.2 million for the third quarter and first nine months of 2026, compared to $15.7 million and $111.3 million for the third quarter and first nine months of 2025.
The Company recorded a reduction in interest expense of $0.1 million and $1.0 million in the third quarter and first nine months of 2026, respectively, compared to interest expense of $0.7 million and $68.3 million in the third quarter and first nine months of 2025, to adjust the fair value of the mandatorily redeemable noncontrolling interest at GHG. The significant adjustment recorded in the first quarter of 2025 is largely related to a substantial increase in the estimated fair value of CSI. On February 25, 2025, the Company and a group of minority shareholders entered into an agreement to settle a significant portion of the mandatorily redeemable noncontrolling interest for a total of $205 million, which consisted of approximately $186.25 million in cash and $18.75 million in Graham Holdings Company Class B common stock.
42


At September 30, 2026, the Company had $853.4 million in borrowings outstanding at an average interest rate of 5.8%, and cash, marketable equity securities and other investments of $1,246.2 million, excluding DBS cash classified as held for sale. At September 30, 2026, the Company had $186.2 million outstanding on its $400 million revolving credit facility.
Non-operating Pension and Postretirement Benefit Income, net
The Company recorded net non-operating pension and postretirement benefit income of $47.6 million and $248.3 million for the third quarter and first nine months of 2026, compared to $31.0 million and $94.3 million for the third quarter and first nine months of 2025.
In the third quarter and first nine months of 2026, the Company recorded a pre-tax, noncash settlement gain of $15.0 million and $151.9 million, respectively, in connection with the purchase of an irrevocable group annuity contract from an insurance company.
In the third quarter of 2026, the Company recorded $3.2 million in expenses related to non-operating SIPs and a VRIP at Kaplan, manufacturing, other businesses and the Corporate office. In the second quarter of 2026, the Company recorded $3.8 million in expenses related to non-operating SIPs at Kaplan, the television broadcasting division, and other businesses and a VRIP at manufacturing. In the first quarter of 2026, the Company recorded $4.1 million in expenses related to non-operating SIPs at Kaplan, the television broadcasting division, manufacturing, other businesses and the Corporate office.
In the third quarter of 2025, the Company recorded $2.5 million in expenses related to non-operating SIPs at Kaplan, the television broadcasting division, manufacturing and other businesses. In the second quarter of 2025, the Company recorded $6.0 million in expenses related to non-operating SIPs at the education and television broadcasting divisions and other businesses. In the first quarter of 2025, the Company recorded $0.6 million in expenses related to non-operating SIPs at other businesses.
Gain (Loss) on Marketable Equity Securities, net
Overall, the Company recognized $15.0 million in net losses and $17.9 million in net gains on marketable equity securities in the third quarter and first nine months of 2026, compared to $84.8 million and $117.0 million in net gains on marketable equity securities in the third quarter and first nine months of 2025.
Other Non-Operating (Expense) Income
The Company recorded total other non-operating expense, net, of $1.2 million for the third quarter of 2026, compared to a nominal net other non-operating income amount for the third quarter of 2025. The 2026 amounts included $1.5 million in foreign currency losses, partially offset by other items. The 2025 amounts included $1.1 million in foreign currency gains and other items; partially offset by $1.5 million in impairments on cost method investments.
The Company recorded total other non-operating expense, net, of $4.1 million for the first nine months of 2026, compared to $20.5 million for the first nine months of 2025. The 2026 amounts included a $5.2 million loss on the sale of KLG and $2.0 million in foreign currency losses, partially offset by a $0.5 million gain on sale of a cost method investment and other items. The 2025 amounts included $14.2 million in impairments on cost method investments and $7.7 million in foreign currency losses; partially offset by a $0.4 million gain on sale of businesses and other items.
Provision for Income Taxes
The Company’s effective tax rate for the first nine months of 2026 and 2025 was 14.6% and 30.6%, respectively.
The Company recognized a U.S. income tax expense of $1.5 million and a benefit of $68.1 million during the third quarter and first nine months of 2026, respectively, in connection with the restructuring and sale of the KLG business. As a result of this significant U.S. income tax benefit, the Company recorded a non-U.S. global minimum corporate top-up income tax benefit of $3.9 million and an expense of $15.3 million in the third quarter and first nine months of 2026, respectively. This accrual relates to non-U.S. jurisdictions that have not yet enacted legislation adopting recent guidance from the Organization for Economic Co-operation and Development (OECD), which would exempt U.S. parent multinational groups from Pillar Two top-up tax on their U.S. source income. The enactment of legislation in the U.K. and other jurisdictions would have a favorable impact on the Company’s income tax provision and could result in a complete reversal of the $15.3 million accrued amount without payment.
The Company’s effective tax rate for the first nine months of 2025 was based on the estimated full year 2025 effective tax rate, which includes the adverse impact of the permanent difference related to the interest expense recorded to adjust the fair value of the mandatorily redeemable noncontrolling interest at GHG.
43


Earnings Per Share
The calculation of diluted earnings per share for the third quarter and first nine months of 2026 was based on 4,242,985 and 4,308,638 weighted average shares outstanding, respectively, compared to 4,377,884 and 4,369,922 for the third quarter and first nine months of 2025. At September 30, 2026, there were 4,185,665 shares outstanding. On September 12, 2024, the Board of Directors authorized the Company to acquire up to 500,000 shares of its Class B common stock; the Company has remaining authorization for 285,953 shares as of September 30, 2026.
Financial Condition: Liquidity and Capital Resources
The Company considers the following when assessing its liquidity and capital resources:
As of
(In thousands)September 30, 2026December 31, 2025
Cash and cash equivalents$154,326 $266,988 
Restricted cash17,756 44,417 
Investments in marketable equity securities and other investments1,074,071 1,088,970 
Total debt853,434 880,756 
Cash generated by operations is the Company’s primary source of liquidity. The Company maintains investments in a portfolio of marketable equity securities, which is considered when assessing the Company’s sources of liquidity. An additional source of liquidity includes the undrawn portion of the Company’s $400 million revolving credit facility, amounting to $210.1 million at September 30, 2026.
During the first nine months of 2026, the Company’s cash and cash equivalents decreased by $87.9 million after adjusting for the inclusion of $24.8 million of cash and cash equivalents included in current assets held for sale following the classification of the Dublin Business School disposal group as held for sale. The decrease in cash and cash equivalents is due to share repurchases; capital expenditures; business acquisitions and dispositions; dividend payments; the redemption of noncontrolling interests; and net repayments of borrowings. The decrease was partially offset by cash generated from operations, proceeds from the net sale of marketable equity securities and the repayment of a related party loan. In the first nine months of 2026, the Company’s borrowings decreased by $27.3 million, primarily due to repayments under the revolving credit facility and commercial notes at the automotive subsidiary, partially offset by increases in other debt.
As of September 30, 2026 and December 31, 2025, the Company had money market investments of $7.9 million and $5.3 million, that are included in cash and cash equivalents. At September 30, 2026, the Company held approximately $116 million in cash and cash equivalents in businesses domiciled outside the U.S. that includes $24.8 million of cash and cash equivalents included in current assets held for sale, of which approximately $2 million is not available for immediate use in operations or for distribution. Additionally, Kaplan’s business operations outside the U.S. retain cash balances to support ongoing working capital requirements, capital expenditures, and regulatory requirements. As a result, the Company considers a significant portion of the cash and cash equivalents balance held outside the U.S. as not readily available for use in U.S. operations.
At September 30, 2026, the fair value of the Company’s investments in marketable equity securities was $1,069.7 million, which includes investments in the common stock of six publicly traded companies. During the first nine months of 2026, the Company purchased $25.0 million of marketable equity securities and sold marketable equity securities that generated proceeds of $54.6 million. At September 30, 2026, the net unrealized gain related to the Company’s investments totaled $814.5 million.
The Company had working capital of $1,017.3 million and $1,042.5 million at September 30, 2026 and December 31, 2025, respectively. The Company maintains working capital levels consistent with its underlying business requirements and consistently generates cash from operations in excess of required interest or principal payments.
At September 30, 2026 and December 31, 2025, the Company had borrowings outstanding of $853.4 million and $880.8 million, respectively. The Company’s borrowings at September 30, 2026 were mostly from $500.0 million of 5.625% unsecured notes due December 1, 2033, $186.2 million in outstanding borrowings under the Company’s revolving credit facility, and real estate and capital term loans of $146.4 million at the automotive subsidiary. The Company’s borrowings at December 31, 2025 were mostly from $500.0 million of 5.625% unsecured notes due December 1, 2033, $222.5 million in outstanding borrowings under the Company’s revolving credit facility, and real estate and capital term loans of $155.9 million at the automotive subsidiary.
44


On November 24, 2025, the Company issued $500 million of 5.625% unsecured eight-year fixed-rate notes due December 1, 2033. Interest is paid semi-annually on June 1 and December 1. Also on November 24, 2025, the Company used the net proceeds from the sale of the notes, together with the borrowings under the revolving credit agreement, to (i) redeem the $400 million of 5.75% unsecured notes due June 1, 2026, (ii) refinance outstanding revolving loans under the existing revolving credit facility, and (iii) repay all amounts outstanding under the Company’s existing $150 million term loan.
In combination with the issuance of the Notes, the Company amended and restated the Second Amended and Restated Five Year Credit Agreement, dated as of May 3, 2022, to, among other things, (i) increase the Company’s borrowing capacity by replacing the existing revolving commitments with a new revolving credit facility in the aggregate principal amount of $400 million, (ii) extend the maturity of the facility to November 24, 2030, and (iii) increase the letter of credit sublimit to $40 million.
On October 21, 2025, the automotive subsidiary borrowed $38.7 million under the delayed draw term loan to finance the acquisition of a Honda automotive dealership, including the real property for the dealership operations.
During the nine months ended September 30, 2026 and 2025, the Company had average borrowings outstanding of approximately $906.7 million and $835.2 million, respectively, at average annual interest rates of approximately 5.8% and 6.0%, respectively. During the nine months ended September 30, 2026 and 2025, the Company incurred net interest expense of $43.2 million and $111.3 million, respectively. Included in the net interest expense for the nine months ended September 30, 2026 and 2025 is a $1.0 million reduction in interest expense and $68.3 million of interest expense, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest (see Notes 7 and 8).
On February 25, 2025, the Company and a group of minority shareholders entered into an agreement to settle a significant portion of the mandatorily redeemable noncontrolling interest related to GHC One, including CSI, for a total of $205 million, which consisted of approximately $186.25 million in cash and $18.75 million in Graham Holdings Company Class B common stock.
The settlement agreement resulted in a $66.2 million increase to the mandatorily redeemable noncontrolling interest obligation, which the Company recorded as interest expense in the first quarter of 2025. The remaining mandatorily redeemable noncontrolling interest obligation related to GHC One and GHC Two was $7.3 million at September 30, 2026.
On October 21, 2026, Moody’s affirmed the Company’s credit rating and maintained the outlook as Stable. On June 15, 2026, Standard & Poor’s affirmed the Company’s credit rating and maintained the outlook as Stable.
The Company’s current credit ratings are as follows:
Moody’sStandard & Poor’s
Long-termBa1BB
OutlookStableStable
The Company expects to fund its estimated capital needs primarily through existing cash balances and internally generated funds, and, as needed, from borrowings under its revolving credit facility. As of September 30, 2026, the Company had $186.2 million outstanding under the $400 million revolving credit facility. In management’s opinion, the Company will have sufficient financial resources to meet its business requirements in the next 12 months, including working capital requirements, capital expenditures, interest payments, potential acquisitions and strategic investments, dividends and stock repurchases.
In summary, the Company’s cash flows for each period were as follows:
Nine Months Ended 
 September 30
(In thousands)20262025
Net cash provided by operating activities$280,832 $318,896 
Net cash used in investing activities(69,721)(98,362)
Net cash used in financing activities(304,609)(290,817)
Effect of currency exchange rate change(1,861)9,533 
Net decrease in cash and cash equivalents and restricted cash$(95,359)$(60,750)
45


Operating Activities. Cash provided by operating activities is net income adjusted for certain non-cash items and changes in assets and liabilities. The Company’s net cash flow provided by operating activities were as follows:
Nine Months Ended 
 September 30
(In thousands)20262025
Net Income$390,370 $192,382 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and goodwill and other asset impairments91,631 86,496 
Amortization of lease right-of-use asset43,707 44,229 
Net pension benefit, settlement gain and early retirement and special separation benefit expense(215,165)(61,090)
Other non-cash activities49,486 (59,958)
Change in operating assets and liabilities(79,197)116,837 
Net Cash Provided by Operating Activities$280,832 $318,896 
Net cash provided by operating activities consists primarily of cash receipts from customers, less disbursements for costs, benefits, income taxes, interest and other expenses.
For the first nine months of 2026 compared to the first nine months of 2025, the decrease in net cash provided by operating activities is primarily driven by changes in operating assets and liabilities, offset by higher net income, net of non-cash adjustments. Changes in operating assets and liabilities were driven by higher purchases of inventory and a significant decrease in the interest expense related to the mandatorily redeemable noncontrolling interest.
Investing Activities. The Company’s net cash flow used in investing activities were as follows:
Nine Months Ended 
 September 30
(In thousands)20262025
Purchases of property, plant and equipment$(65,013)$(48,618)
Net (payments on) proceeds from disposition of businesses, property, plant and equipment and investments(37,900)7,747 
Net proceeds from sales (purchases) of marketable equity securities29,622 (29,823)
Proceeds from repayment of related party loan20,000 — 
Investments in certain businesses, net of cash acquired(18,362)(19,486)
Investments in equity affiliates and cost method investments(204)(10,512)
Other2,136 2,330 
Net Cash Used in Investing Activities$(69,721)$(98,362)
Capital Expenditures. The amounts reflected in the Company’s Condensed Consolidated Statements of Cash Flows are based on cash payments made during the relevant periods, whereas the Company’s capital expenditures for the first nine months of 2026 and 2025 disclosed in Note 16 to the Condensed Consolidated Financial Statements include assets acquired during the period. The Company estimates that its capital expenditures will be in the range of $95 million to $105 million in 2026.
Disposition of Businesses. In May 2026, Kaplan completed the sale of the KLG business, which is included in Kaplan International. KLG comprised Kaplan International Languages, Alpadia Language Schools, Azurlingua and English as a second language (ESL) Education. In April 2025, Kaplan completed the sale of a small business, BridgeU Limited, which was included in Kaplan International. In the first half of 2025, WGB completed the sale of various websites and related businesses that made up the WGB operations. All remaining WGB operations were substantially shut down by the end of the third quarter of 2025.
Net proceeds from sales (purchases) of marketable equity securities. During the first nine months of 2026, the Company sold marketable equity securities that generated proceeds of $54.6 million. There were no sales of marketable equity securities during the first nine months of 2025. The Company purchased $25.0 million and $29.8 million of marketable equity securities during the first nine months of 2026 and 2025, respectively.
Proceeds from repayment of related party loan. During the first nine months of 2026, the Company received the $20.0 million from Purdue Global related to the advance during the initial KU transaction.
Acquisitions. During the first nine months of 2026, the Company acquired two small businesses, one in March and one in July, both of which are included in other healthcare businesses. In July 2025, Hoover acquired 100% of Arconic Architectural Products, LLC, a wholly-owned subsidiary of Arconic Corporation, which manufactures aluminum cladding products and operates within the broader non-residential materials space from its facility in
46


Eastman, GA. A significant portion of the purchase price was funded by the Company’s assumption of $107.5 million in net pension obligations. In June 2025, Kaplan acquired one small business which is included in its supplemental education division.
Transactions with equity affiliates. In September 2025, the Company invested an additional $29.3 million in its equity affiliate Intersection. Intersection used a portion of the additional investment to settle, in a non-cash exchange, $19.3 million of the outstanding amount owed to the Company on the $30 million term loan extended in April 2023.
Financing Activities. The Company’s net cash flow used in financing activities were as follows:
Nine Months Ended 
 September 30
(In thousands)20262025
Common shares repurchased$(198,598)$(3,468)
Net (payments) borrowings under revolving credit facility(31,258)600 
Repayments of borrowings(21,535)(22,089)
Net proceeds from (repayments of) vehicle floor plan payable4,863 (27,897)
Issuance of borrowings1,800 — 
Dividends paid(24,285)(23,508)
Purchase of noncontrolling interests(17,526)(1,761)
Distributions paid to noncontrolling interests(5,269)(191,609)
Other(12,801)(21,085)
Net Cash Used in Financing Activities$(304,609)$(290,817)
Common Stock Repurchases. During the first nine months of 2026, the Company purchased a total of 176,529 shares of its Class B common stock at a cost of approximately $200.6 million, including commissions and accrued excise tax of $2.0 million. On September 12, 2024, the Board of Directors authorized the Company to acquire up to 500,000 shares of its Class B common stock. The Company did not announce a ceiling price or time limit for the purchases. At September 30, 2026, the Company had remaining authorization from the Board of Directors to purchase up to 285,953 shares of Class B common stock.
Borrowings and Vehicle Floor Plan Payable. In the first nine months of 2026, the Company repaid amounts borrowed under the $400 million revolving credit facility and the commercial notes at the automotive subsidiary, and made additional borrowings of other debt. In the first nine months of 2025, the Company repaid amounts borrowed under the term loan, commercial notes at the automotive subsidiary and other debt. In the first nine months of 2026 and 2025, the Company used vehicle floor plan financing to fund the purchase of new, used and service loaner vehicles at its automotive subsidiary. The proceeds from (repayments of) vehicle floor plan payable fluctuates with changes in the amount of vehicle inventory held by the automotive dealerships.
Dividends. The quarterly dividend rate per share was $1.88 and $1.80 for the first nine months of 2026 and 2025, respectively. The Company expects to pay a dividend of $7.52 per share in 2026.
Transactions with minority shareholders. In July 2026, CSI exercised its call option to purchase some of the minority-owned interest of CSI for $1.9 million. CSI paid cash of $0.2 million and entered into promissory notes for the remaining $1.7 million. In March 2026, the Company acquired some of the minority-owned shares of CSI for a total amount of $41.0 million. The Company paid cash of $16.4 million and entered into promissory notes with the minority owners for the remaining $24.6 million. In January 2026, pursuant to the exercise of a put right, the Company purchased some of the minority-owned interest of Clarus for $1.0 million.
In October 2026, the Company acquired the 49% minority-owned shares of Skin Clique for $18.4 million; the Company now owns 100% of Skin Clique.
On February 25, 2025, the Company and a group of minority shareholders entered into an agreement to settle a significant portion of the mandatorily redeemable noncontrolling interest related to GHC One, including CSI, for a total of $205 million, which consisted of approximately $186.25 million in cash and $18.75 million in Graham Holdings Company Class B common stock.
Other. During the first nine months of 2026 and 2025, the Company paid $0.4 million and $7.0 million, respectively, related to deferred payments from prior acquisitions.
There were no other significant changes to the Company’s contractual obligations or other commercial commitments from those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
47


Forward-Looking Statements
All public statements made by the Company and its representatives that are not statements of historical fact, including certain statements in this report, in the Company’s Annual Report on Form 10-K and in the Company’s 2025 Annual Report to Stockholders, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on expectations, forecasts, and assumptions by the Company’s management and involve a number of risks, uncertainties, and other factors that could cause actual results to differ from those stated, including, without limitation, comments about expectations related to acquisitions or dispositions or related business activities, the Company’s business strategies and objectives, the prospects for growth in the Company’s various business operations, the Company’s future financial performance, and the risks and uncertainties described in Item 1A of the Company’s Annual Report on Form 10-K. Accordingly, undue reliance should not be placed on any forward-looking statement made by or on behalf of the Company. The Company assumes no obligation to update any forward-looking statement after the date on which such statement is made, even if new information subsequently becomes available.
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
The Company is exposed to market risk in the normal course of its business due primarily to its ownership of marketable equity securities, which are subject to equity price risk; to its borrowing and cash-management activities, which are subject to interest rate risk; and to its foreign business operations, which are subject to foreign exchange rate risk. The Company’s market risk disclosures set forth in its 2025 Annual Report filed on Form 10-K have not otherwise changed significantly.
Item 4. Controls and Procedures.
(a) Evaluation of Disclosure Controls and Procedures
An evaluation was performed by the Company’s management, with the participation of the Company’s Chief Executive Officer (principal executive officer) and the Company’s Chief Financial Officer (principal financial officer), of the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), as of September 30, 2026. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures, as designed and implemented, are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, in a manner that allows timely decisions regarding required disclosure.
(b) Changes in Internal Control Over Financial Reporting
There has been no change in the Company’s internal control over financial reporting during the quarter ended September 30, 2026 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
48


PART II. OTHER INFORMATION
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
During the quarter ended September 30, 2026, the Company purchased shares of its Class B Common Stock as set forth in the following table:
PeriodTotal Number of Shares Purchased
Average Price Paid per Share(1)
Total Number of Shares Purchased as Part of Publicly Announced Plan(2)
Maximum Number of Shares that May Yet Be Purchased Under the Plan(2)
July 1 - 3120,893 $1,182.59 20,893 331,118 
August 1 - 3117,846 1,192.72 17,846 313,272 
September 1 - 3027,319 1,148.54 27,319 285,953 
66,058 $1,171.25 66,058 
(1) Average price paid per share includes costs associated with repurchases, including commissions and excise taxes.
(2) On September 12, 2024, the Company’s Board of Directors authorized the Company to purchase, on the open market or otherwise, up to 500,000 shares of its Class B Common Stock. This authorization includes shares that remained under the previous authorization. There is no expiration date for this authorization. Share purchases made during the quarter ended September 30, 2026 were open market transactions or transactions to settle employee tax withholding obligations related to the vesting of restricted stock awards.
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the quarter ended September 30, 2026, the following directors or officers of the Company (as defined in Rule 16a-1(f) of the Exchange Act) adopted a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K:
On September 22, 2026, Marcel A. Snyman, the Company’s Vice President and Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale of an aggregate of up to 213 shares of the Company’s Class B common stock acquired upon the vesting of restricted stock awards held by Mr. Snyman. The actual number of shares sold under the trading arrangement will be net of shares withheld for taxes upon vesting and settlement of the restricted stock awards subject to the trading plan. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The first date that sales of any shares are permitted to be sold under the trading arrangement is January 6, 2027, and subsequent sales under the trading arrangement may occur on a regular basis for the duration of the trading arrangement until February 26, 2027, or earlier if all transactions under the trading arrangement are completed.
During the quarter ended September 30, 2026, no other directors or officers of the Company (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K.
49


Item 6. Exhibits.
Exhibit Number 
Description 
3.1
Restated Certificate of Incorporation of the Company dated November 13, 2003 (incorporated by reference to Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2003).
3.2
Certificate of Amendment, effective November 29, 2013, to the Restated Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K dated November 29, 2013).
3.3
By-Laws of the Company as amended and restated through September 12, 2024 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K dated September 12, 2024).
4.1
Senior Notes Indenture dated as of November 24, 2025, between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K dated November 24, 2025).
31.1
Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
31.2
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
32
Section 1350 Certification of the Chief Executive Officer and the Chief Financial Officer. *
101.INS
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101
*     Furnished herewith.
50


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
GRAHAM HOLDINGS COMPANY
(Registrant)
Date: October 29, 2026/s/ Timothy J. O’Shaughnessy
Timothy J. O’Shaughnessy,
President & Chief Executive Officer
(Principal Executive Officer)
Date: October 29, 2026/s/ Wallace R. Cooney
Wallace R. Cooney,
Chief Financial Officer
(Principal Financial Officer)
51

Keep reading